Cash and cash equivalentsus-gaap:CashAndCashEquivalentsAtCarryingValue
167,611,000USD · at Dec 31, 2025
79,551,000USD · at Dec 31, 2024
+88,060,000+110.7%
Net cash from operating activitiesus-gaap:NetCashProvidedByUsedInOperatingActivities
319,306,000USD · Jan 1, 2025 to Dec 31, 2025
136,676,000USD · Jan 1, 2024 to Dec 31, 2024
+182,630,000+133.6%
Values as tagged in the filing's inline XBRL, resolved by accession rather than by period matching. When a value is not tagged, we show that instead of estimating it. FY2025: 0001736297-26-000010 · FY2024: 0001736297-25-000003
What the company says for the first time
Paragraphs with no counterpart in the prior filing.
11 material additions
Item 1A · Risk Factors
5 of 8 shown · Ordered by the model, quote-checked
01·Added·Item 1A › Risks Related to Our Business › Adverse changes in the political, regulatory, and economic policies of governments in connection with trade with China and Chinese customers have reduced the demand for our products and damaged our business.
Summary · quote-checked
Adds risks involving Chinese customer behavior, unreliable-supplier designation, investment and data restrictions, and indirect effects of export controls.
The new paragraph discloses additional dependencies, potential government designation, regulatory restrictions, and customer responses that substantively expand the company’s stated business risks.
Why the model ranked it here
This adds a direct China-related dependency involving customer behavior, export restrictions, input costs, and potential unreliable-supplier designation.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
Regulatory activity, such as tariffs, export controls, economic sanctions, and restrictions on investment and data transfers as well as vigorous enforcement of U.S. export controls and economic sanctions laws have in the past and may continue to materially limit our ability to make sales to our customers in China, which has in the past and may continue to harm our results of operations, reputation, and financial condition. Due to the U.S. government restricting sales to certain customers in China, sales to some of our customers may require licenses in order for us to export our products; however, there can be no assurances that requests for licenses will be approved by the U.S. government. Further, augmentation of restricted or prohibited persons lists maintained by the U.S. government could reduce our ability to sell to certain customers. Fluid tariff policies of both the U.S. and Chinese governments may reduce demand for our products and could [added] increase input costs. Moreover, concerns that U.S. companies may not be reliable suppliers as a result of these and other actions has caused, and may in the future cause, some of our customers in China to amass large inventories of our products well in advance of need or caused some of our customers to replace our products in favor of products from other suppliers. Additionally, the Chinese government adopted a law with respect to unreliable suppliers. Any designation as an unreliable supplier may have an adverse impact on our business and operations. Recent U.S. government restrictions on investments into China by U.S. persons and regarding access by Chinese persons to certain personal data relating to U.S. persons could hinder our Chinese operations. In addition, there may be indirect impacts to our business that we cannot easily quantify such as the fact that some of our other customers' systems may also be impacted by export restrictions.
Cite this change
"increase input costs. Moreover, concerns that U.S. companies may not be reliable suppliers as a result of these and other actions has caused, and may in the future cause, some of our customers in China to amass large inventories of our products well in advance of need or caused some of our customers to replace our products in favor of products from other suppliers. Additionally, the Chinese government adopted a law with respect to unreliable suppliers. Any designation as an unreliable supplier may have an adverse impact on our business and operations. Recent U.S. government restrictions on investments into China by U.S. persons and regarding access by Chinese persons to certain personal data relating to U.S. persons could hinder our Chinese operations. In addition, there may be indirect impacts to our business that we cannot easily quantify such as the fact that some of our other customers' systems may also be impacted by export restrictions."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
02·Added·Item 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.
Summary · quote-checked
Added disclosure of restrictions on personal data transfers, including a U.S. rule involving countries of concern and potential sanctions.
The paragraph introduces a specific regulation, jurisdictional restrictions involving China, and criminal, civil, and program-exclusion consequences, changing the disclosed regulatory risk.
Why the model ranked it here
This introduces specific restrictions on personal-data transfers with potentially severe sanctions and program-exclusion consequences.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] Regulators and legislators across the world are also increasingly scrutinizing and restricting certain personal data transfers. For example, the Department of Justice's January 8, 2025, rule on "Preventing Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons," prohibits or restricts certain data transactions involving countries of concern, including China. Actual or alleged violations of these regulations may be punishable by criminal and/or civil sanctions and may result in exclusion from participation in federal and state programs.
Cite this change
"Regulators and legislators across the world are also increasingly scrutinizing and restricting certain personal data transfers. For example, the Department of Justice's January 8, 2025, rule on "Preventing Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons," prohibits or restricts certain data transactions involving countries of concern, including China. Actual or alleged violations of these regulations may be punishable by criminal and/or civil sanctions and may result in exclusion from participation in federal and state programs."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
03·Added·Item 1A › Risks Related to Our Business › Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.
Summary · quote-checked
Adds disclosure of geopolitical cyber conflicts, cybersecurity incidents, data breaches, malware, vulnerabilities, and resulting information loss or business disruption.
The new paragraph identifies additional cyber threats, actors, affected systems, and consequences, substantively expanding disclosed business risks.
Why the model ranked it here
This expands the disclosed cybersecurity exposure to geopolitical attacks, third-party systems, data loss, business disruption, and proprietary-information compromise.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
Cyber-attacks are increasing in number and sophistication, are well-financed, in some cases supported by state actors, and are designed to not only attack, but also to evade detection, and are being facilitated or enhanced by evolving technologies, including AI. Since the techniques used to obtain unauthorized access to systems and data, or to otherwise sabotage them, change frequently and are often not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Attempts to disrupt or gain unauthorized access to our and our third-party vendors' information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or facilitated by evolving technologies [added] such as AI. Geopolitical instability may also increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful cybersecurity incidents, data breaches, or other unauthorized access to our information systems or the systems of our third-party service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or the misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties.
Cite this change
"such as AI. Geopolitical instability may also increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful cybersecurity incidents, data breaches, or other unauthorized access to our information systems or the systems of our third-party service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or the misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
04·Added·Item 1A › Risks Related to Our Business › The adoption, use, and commercialization of AI technology, and the continued rapid pace of developments in the AI field, are inherently uncertain. Failure by our customers to continue to adopt or invest in AI infrastructure to support AI use cases in their systems, or our ability to keep up with evolving AI infrastructure requirements, could have a material adverse effect on our business, financial condition, and results of operations.
Summary · quote-checked
Adds disclosure about increasingly complex AI regulation, compliance resources, customer commercialization delays, demand, and adoption risks.
The new paragraph introduces regulatory uncertainty, compliance obligations, potential commercialization delays, reduced customer demand, and adoption effects, substantively expanding disclosed risks.
Why the model ranked it here
This links increasingly complex AI regulation to compliance burdens, customer commercialization delays, demand, and adoption risks.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] The AI regulatory environment is increasingly complex and uncertain. For example, in the United States, states have advanced, and in some cases passed, laws focusing on AI, while the federal government has pursued a deregulatory agenda. Significant resources will be required to design, develop, test and maintain our products to help ensure that AI is implemented and deployed in accordance with applicable law and regulation and in a manner intended to comply with applicable laws and regulations and mitigate foreseeable risks. Our customers may also become subject to such existing or upcoming AI laws and regulations, which could cause a delay or impediment to the commercialization of AI technology and could lead to a decrease in demand for our customers' AI systems, and may adversely affect our business, financial condition, and results of operations. In addition, uncertainty regarding the direction of AI regulation may affect customers' adoption of AI, which could adversely affect our business.
Cite this change
"The AI regulatory environment is increasingly complex and uncertain."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
05·Added·Item 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.
Summary · quote-checked
Adds disclosure that using AI may create cybersecurity, privacy, intellectual property, regulatory, operational, competitive and reputational risks.
The new paragraph identifies specific AI-related risks, including bias, harmful content, privacy-law exposure, confidentiality compromise and intellectual property infringement or ownership uncertainty.
Why the model ranked it here
This discloses that the company’s own and vendors’ AI use creates broad cybersecurity, privacy, intellectual-property, legal, operational, and reputational exposure.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] Our use of AI in our business processes may also subject us to cybersecurity, data privacy, IT, intellectual property, regulatory, legal, operational, competitive, reputational and other risks and challenges that could affect our business. Use of AI by us or our vendors could result in bias, discrimination, or harmful or inaccurate content that may be actionable under privacy, data protection, and emerging AI laws. The use of certain AI technology can also give rise to intellectual property risks, including by disclosing or otherwise compromising our confidential or proprietary intellectual property and intellectual property infringement, or by undermining our ability to assert or defend ownership rights in intellectual property created with the assistance of AI tools.
Cite this change
"Our use of AI in our business processes may also subject us to cybersecurity, data privacy, IT, intellectual property, regulatory, legal, operational, competitive, reputational and other risks and challenges that could affect our business. Use of AI by us or our vendors could result in bias, discrimination, or harmful or inaccurate content that may be actionable under privacy, data protection, and emerging AI laws. The use of certain AI technology can also give rise to intellectual property risks, including by disclosing or otherwise compromising our confidential or proprietary intellectual property and intellectual property infringement, or by undermining our ability to assert or defend ownership rights in intellectual property created with the assistance of AI tools."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Added disclosure that gross margin decreased due primarily to product mix from shipping more hardware modules.
The new paragraph states a changed profitability result and identifies its driver; this is substantive MD&A information, not merely a period or figure roll-forward.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] Gross margin decreased 70 bps to 75.7% for the year ended December 31, 2025 from 76.4% for the same period in 2024, primarily driven by product mix as we shipped more hardware modules.
Cite this change
"Gross margin decreased 70 bps to 75.7% for the year ended December 31, 2025 from 76.4% for the same period in 2024, primarily driven by product mix as we shipped more hardware modules."
Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
02·Added·Item 7 › Non-GAAP Operating Income and Non-GAAP Operating Margin
Summary · quote-checked
Added a definition of acquisition-related costs and identified the types of third-party expenses included.
The new paragraph discloses a specific non-GAAP cost category and its components, adding substantive information about expenses associated with business combinations.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] (2) Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees.
Cite this change
"(2) Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees."
Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
03·Added·Item 7 › Revenue Recognition
Summary · quote-checked
Added disclosure describing customer warrants, performance-based vesting conditions, and their treatment as consideration payable reducing recognized revenue.
The new paragraph discloses a customer-related warrant arrangement and an associated revenue-reduction obligation, revealing a new instrument and accounting exposure.
Filing text · FY2024 10-K · filed Feb 14, 2025
No corresponding language in the FY2024 10-K.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] We account for the warrants issued to a customer as consideration payable as we did not receive a distinct good or service in exchange for the warrants. The shares underlying the warrants vest upon the achievement of specified tranches of global payments by the customer and its affiliates. As it becomes probable that the performance-based vesting conditions underlying the warrants will be achieved and the related revenue is recognized, we recognize the related grant date fair value of the warrants as a reduction of revenue for each sales transaction in proportion to total expected cumulative sales volume resulting in achievement of the vesting conditions. For more information, see Note 10 - Common Stock Warrants in the Notes to the Consolidated Financial Statements set forth in Part II, Item 8 of this Annual Report on Form 10-K.
Cite this change
"We account for the warrants issued to a customer as consideration payable as we did not receive a distinct good or service in exchange for the warrants."
Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
What the company no longer says
Paragraphs of the prior filing that this filing dropped. Only last year's text can show these.
22 material removals
Item 1A · Risk Factors
2 of 8 shown · Ordered by the model, quote-checked
01·Removed·Item 1A › Risks Related to Our Business › We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. If our remediation of the material weaknesses is not effective, or we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.
Summary · quote-checked
The current filing removed disclosure that the company had identified material weaknesses in internal control over financial reporting.
Removing this disclosure changes the stated condition regarding financial reporting controls and a potential material misstatement risk.
Why the model ranked it here
The removal changes the company’s stated condition regarding material weaknesses in financial reporting controls and the risk of material misstatement.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis. We have identified material weaknesses in our internal control over financial reporting.
Filing text · FY2025 10-K · filed Feb 20, 2026
No corresponding language in the FY2025 10-K.
Cite this change
"A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis. We have identified material weaknesses in our internal control over financial reporting."
Astera Labs,, Form 10-K for FY2024, Item 1A, accession 0001736297-25-000003, filed 14 February 2025.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
02·Removed·Item 1A › Risks Related to Our Business › We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. If our remediation of the material weaknesses is not effective, or we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.
Summary · quote-checked
The company removed a disclosure describing inadequate risk assessment and insufficient controls over financial reporting, including segregation of duties.
The removed paragraph disclosed specific material weaknesses in internal control over financial reporting, including risks involving journal entries and account reconciliations; its removal changes the disclosed control risk.
Why the model ranked it here
The removed disclosure covered inadequate risk assessment, segregation of duties, journal entries, and account reconciliations, materially changing the reported control-risk profile.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] We did not adequately design and maintain an effective risk assessment process at a sufficient precision level to identify risks of material misstatement in our consolidated financial statements. Specifically, the implementation of controls was not sufficient to respond to risks of material misstatement to financial reporting, including a lack of effectively designed controls over segregation of duties, particularly over the preparation and review of journal entries and account reconciliations.
Filing text · FY2025 10-K · filed Feb 20, 2026
No corresponding language in the FY2025 10-K.
Cite this change
"We did not adequately design and maintain an effective risk assessment process at a sufficient precision level to identify risks of material misstatement in our consolidated financial statements. Specifically, the implementation of controls was not sufficient to respond to risks of material misstatement to financial reporting, including a lack of effectively designed controls over segregation of duties, particularly over the preparation and review of journal entries and account reconciliations."
Astera Labs,, Form 10-K for FY2024, Item 1A, accession 0001736297-25-000003, filed 14 February 2025.
3 of 14 shown · Ordered by the model, quote-checked
01·Removed·Item 7 › Revenue Recognition
Summary · quote-checked
The revenue recognition disclosure describing receivables, deferred revenue, and performance obligations extending beyond one year was removed.
Removing the paragraph eliminates substantive disclosure about deferred revenue obligations and contracts with performance obligations extending beyond one year, not merely presentation or calculation mechanics.
Why the model ranked it here
This removes disclosure of deferred revenue and performance obligations extending beyond one year, obscuring the company’s stated contractual obligations.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] Accounts receivable are recorded when the customer has been billed or the right to consideration is unconditional. We record deferred revenue when we have received consideration, or an amount of consideration is due from the customer, and we have a future obligation to transfer products or services. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year.
Filing text · FY2025 10-K · filed Feb 20, 2026
No corresponding language in the FY2025 10-K.
Cite this change
"Accounts receivable are recorded when the customer has been billed or the right to consideration is unconditional. We record deferred revenue when we have received consideration, or an amount of consideration is due from the customer, and we have a future obligation to transfer products or services. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year."
Astera Labs,, Form 10-K for FY2024, Item 7, accession 0001736297-25-000003, filed 14 February 2025.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
02·Removed·Item 7 › Revenue Recognition
Summary · quote-checked
The revenue recognition disclosure about distributor resale pricing and subsequent credit memos was removed.
The removed paragraph described distributor pricing practices and the company’s obligation to issue credit memos, changing disclosed revenue-recognition mechanics.
Why the model ranked it here
This removes the explanation of distributor resale pricing and credit memos, which is important for understanding the company’s revenue-recognition mechanics.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] We sell the majority of our products to distributors at a fixed list price. Distributors are authorized to resell our products to customers at a range of individually negotiated price points based on a variety of factors, including customer, product, quantity, geography, and competitive differentiation. The majority of our distributors' resales are priced at a discount from list price (the original purchase price). After the resale transaction is completed, we issue credit memos to the distributor for the price adjustments.
Filing text · FY2025 10-K · filed Feb 20, 2026
No corresponding language in the FY2025 10-K.
Cite this change
"We sell the majority of our products to distributors at a fixed list price. Distributors are authorized to resell our products to customers at a range of individually negotiated price points based on a variety of factors, including customer, product, quantity, geography, and competitive differentiation. The majority of our distributors' resales are priced at a discount from list price (the original purchase price). After the resale transaction is completed, we issue credit memos to the distributor for the price adjustments."
Astera Labs,, Form 10-K for FY2024, Item 7, accession 0001736297-25-000003, filed 14 February 2025.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
03·Removed·Item 7 › Initial Public Offering
Summary · quote-checked
The current MD&A omits disclosure of cumulative stock-based compensation expense and the related tax withholding obligation paid after the IPO.
The removed paragraph disclosed specific recognized compensation expense, an IPO-triggered vesting event, and a related tax withholding payment, changing the stated obligations and transaction disclosure.
Why the model ranked it here
This removes disclosure of IPO-triggered stock-based compensation recognition and the related tax withholding obligation, eliminating a significant stated compensation-related cash requirement.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] We recognized $88.9 million of cumulative stock-based compensation expense associated with the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO. Based on our IPO price of $36.00 per share, our tax withholding obligation in connection with the vesting of these RSUs was $20.1 million, which we paid in the first quarter of 2024.
Filing text · FY2025 10-K · filed Feb 20, 2026
No corresponding language in the FY2025 10-K.
Cite this change
"We recognized $88.9 million of cumulative stock-based compensation expense associated with the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO."
Astera Labs,, Form 10-K for FY2024, Item 7, accession 0001736297-25-000003, filed 14 February 2025.
Paragraphs that changed between the two filings, shown as a word diff.
99 material changes
Item 1A · Risk Factors
3 of 61 shown · Ordered by the model, quote-checked
01·Changed·Item 1A › Risks Related to Our Business › We have a limited history of generating net income, and if we are unable to achieve adequate revenue growth while our expenses increase, we may not maintain profitability in the future.
Summary · quote-checked
The disclosure changes from a history of net losses to limited net income history and adds 2025 net income and retained earnings information.
Reporting net income and retained earnings materially changes the stated profitability and accumulated-deficit position, beyond a routine annual roll-forward.
Why the model ranked it here
The company now describes a limited history of net income rather than a history of net losses, materially changing the reader’s understanding of its profitability and retained-earnings position.
Filing text · FY2024 10-K · filed Feb 14, 2025
We have a history of generating net [removed] losses. We incurred net losses of $83.4 million and $26.3 million for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, we had [removed] an accumulated deficit of $208.8 million and $125.4 million, respectively. [removed] These losses and [removed] our accumulated deficit are a result of the substantial investments we have made to grow our business. We expect our costs will increase over time and our losses may continue if such increases in costs are not more than fully offset by increases in our revenue. We expect to continue to invest significant additional funds in expanding our business and research and development activities as we continue to develop new products. We have experienced and expect to continue to incur additional general and administrative expenses as a result of our growth and increased costs to support our operations as a public company. Historically, our costs have increased over the years due to these factors, and we expect to continue to incur increasing costs to support our anticipated future growth.
Filing text · FY2025 10-K · filed Feb 20, 2026
We have a [added] limited history of generating net [added] income. We recorded net income of $219.1 million and incurred net losses of $83.4 million and $26.3 million for the years ended December 31, [added] 2025, 2024 and 2023, respectively. As of December 31, [added] 2025, 2024 and 2023, we had [added] retained earnings of $10.3 million and accumulated deficits of $208.8 million and $125.4 million, respectively. [added] Our historical losses and [added] accumulated deficits were a result of the substantial investments we have made to grow our business. We expect our costs will [added] continue to increase over time and our losses may continue if such increases in costs are not more than fully offset by increases in our revenue. We expect to continue to invest significant additional funds in expanding our business and research and development activities as we continue to develop new products. We have experienced and expect to continue to incur additional general and administrative expenses as a result of our growth and increased costs to support our operations as a public company. Historically, our costs have increased over the years due to these factors, and we expect to continue to incur increasing costs to support our anticipated future growth.
Cite this change
"We have a limited history of generating net income. We recorded net income of $219.1 million and incurred net losses of $83.4 million and $26.3 million for the years ended December 31, 2025, 2024 and 2023, respectively."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
02·Changed·Item 1A › Risks Related to Our Business › A substantial portion of our revenue is driven by a limited number of our end customers, and the loss of, or a significant reduction in, demand from one or a few of our top end customers would adversely affect our operations and financial condition.
Summary · quote-checked
Customer concentration increased substantially, with one end customer exceeding 70% of revenue and the top three accounting for approximately 86%.
The figures change the stated customer-concentration exposure, from no customer above 40% and top three at approximately 80% to one above 70% and top three at approximately 86%.
Why the model ranked it here
Customer concentration has increased substantially, making dependence on a single end customer a far more significant risk to revenue and operations.
Filing text · FY2024 10-K · filed Feb 14, 2025
A substantial portion of our revenue is driven by a limited number of end customers. In [removed] 2024, no end customer represented more than [removed] 40% of our revenue; the top three end customers represented an aggregate of approximately [removed] 80% of our revenue. Our distributors and end customers' manufacturing partners provide us with information in their purchase orders about which end customer will receive the products purchased. This data allows us to estimate the portion of our revenue that is due to specific end customer demand. We anticipate that we will continue to be dependent on a limited number of end customers for a significant portion of our revenue in the future, and in some cases, the portion of our revenue attributable to certain end customers may increase in the future. However, we may not be able to maintain or increase sales to certain of our top end customers for a variety of reasons, including the following:
Filing text · FY2025 10-K · filed Feb 20, 2026
A substantial portion of our revenue is driven by a limited number of end customers. In [added] 2025, one end customer represented more than [added] 70% of our revenue; the top three end customers represented an aggregate of approximately [added] 86% of our revenue. Our distributors and end customers' manufacturing partners provide us with information in their purchase orders about which end customer will receive the products purchased. This data allows us to estimate the portion of our revenue that is due to specific end customer demand. We anticipate that we will continue to be dependent on a limited number of end customers for a significant portion of our revenue in the future, and in some cases, the portion of our revenue attributable to certain end customers may increase in the future. However, we may not be able to maintain or increase sales to certain of our top end customers for a variety of reasons, including the following:
Cite this change
"In 2025, one end customer represented more than 70% of our revenue; the top three end customers represented an aggregate of approximately 86% of our revenue."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
03·Changed·Item 1A › Risks Related to Our Business › Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.
Summary · quote-checked
The disclosure changes from hypothetical cybersecurity events to stating that the company and vendors have experienced cyber-attacks or unauthorized intrusions.
The modality changes from potential events to reported experience, materially changing the asserted cybersecurity exposure; related notification, disclosure, fine, and sanction language was also removed.
Why the model ranked it here
The disclosure changes cybersecurity from a hypothetical threat to an event the company and its vendors have actually experienced.
Filing text · FY2024 10-K · filed Feb 14, 2025
Cyber-attacks are increasing in number and sophistication, are well-financed, in some cases supported by state actors, and are designed to not only attack, but also to evade detection. Since the techniques used to obtain unauthorized access to systems and data, or to otherwise sabotage them, change frequently and are often not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Geopolitical instability may increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful security breaches, data breaches, or other unauthorized access to our information systems or the systems of our third-party service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties. Despite our internal controls and investment in security measures, we have in the past, and may again in the future, be subject to cyber-attacks or unauthorized network intrusions. [removed] These events, should they occur, could disrupt our business and result in, among other things, unfavorable publicity, damage to our reputation, loss of our trade secrets and other competitive information, litigation by affected [removed] parties and possible financial obligations for liabilities and damages related to the theft or misuse of [removed] such information, significant remediation costs, disruption of key business operations, and significant diversion of our [removed] resources, legal notifications and disclosures, as well as fines and other sanctions resulting from any related breaches of data privacy laws and regulations (such as the CCPA), any of which could have a material adverse effect on our business, profitability, and financial condition. In addition, despite our internal controls and processes, malicious code, and cybersecurity vulnerabilities in our products and services may expose our customers to cyberattacks and other security risks, which may result in claims, regulatory action, or reputational damage. While we may be entitled to damages if an adverse event arises from our third-party service providers' failure to perform under their agreements with us, any award may be insufficient to cover the actual costs incurred by us and, as a result of a service provider's failure to perform, we may be unable to collect any damages.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] Despite our internal controls and investment in security measures, we, and our third-party vendors, have been subject to cyber-attacks or unauthorized network intrusions. Should a cybersecurity incident or data breach occur, it could disrupt our business and result in, among other things, unfavorable publicity, damage to our reputation, loss of our trade secrets and other competitive information, litigation by affected [added] parties, possible financial obligations for liabilities and damages related to the theft or misuse of [added] any personal or confidential information, significant remediation costs, disruption of key business operations, and significant diversion of our [added] resources. Any of such events could have a material adverse effect on our business, profitability, and financial condition. In addition, despite our internal controls and processes, malicious code, and cybersecurity vulnerabilities in our products and services may expose our customers to cyberattacks and other security risks, which may result in claims, regulatory action, or reputational damage. While we may be entitled to damages if an adverse event arises from our third-party service providers' failure to perform under their agreements with us, any award may be insufficient to cover the actual costs incurred by us and, as a result of a service provider's failure to perform, we may be unable to collect any damages.
Cite this change
"Despite our internal controls and investment in security measures, we, and our third-party vendors, have been subject to cyber-attacks or unauthorized network intrusions."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
04·Changed·Item 1A › General Risk Factors › We have incurred, and will continue to incur, increased costs as a result of operating as a public company, and our management is required to devote substantial time to support compliance with our public company responsibilities and corporate governance practices.
Summary · quote-checked
The disclosure shifts from emerging-growth-company exemptions and investor attractiveness risks to enhanced public-company obligations, costs, management demands, and reporting risks.
The paragraph changes the company’s stated regulatory status, obligations, compliance costs, management burden, and potential effects on reporting, operations, investor confidence, and market price.
Why the model ranked it here
The company’s stated regulatory status has changed to enhanced public-company obligations, bringing greater reporting, control, compliance, and management requirements.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] We are an "emerging growth company" within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation [removed] requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive [removed] compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory [removed] vote on executive [removed] compensation and stockholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years or the earlier of, (i) the last day of the fiscal year in which we have total annual gross revenue of $1.235 billion or more, (ii) the date on which we have issued more than $1.0 billion in non-convertible debt during the previous three years, or (iii) the date on which we are deemed to be a large accelerated filer under the rules of the SEC. Investors may find our securities less attractive because we rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities, and the [removed] trading prices of our [removed] securities may be more volatile.
Filing text · FY2025 10-K · filed Feb 20, 2026
As a public company, we have incurred, and will continue to incur, significant finance, legal, accounting, and other expenses, including director and officer liability insurance, that we did not incur as a private company, and which we expect to further increase following our recent transition to large accelerated filer status. The Sarbanes-Oxley Act, the Dodd- Frank Act, stock exchange listing requirements, the reporting requirements of the Exchange Act and other applicable securities rules and regulations impose various requirements on public companies in the United States. As a [added] large accelerated filer, we are subject to enhanced reporting, internal control, and compliance obligations, including auditor attestation [added] of internal control over financial reporting, additional reporting obligations regarding executive [added] compensation, and the requirement to hold nonbinding advisory [added] votes on executive [added] compensation, and our management and other personnel devote a substantial amount of time to support compliance with these requirements. Moreover, these rules and regulations have increased, and will continue to increase, our legal and financial compliance costs and make certain activities more time-consuming and costly. We cannot predict the amount or timing of these additional costs that we will incur as a public company, and the resulting strain on management resources could adversely affect our results of operations and financial condition. These enhanced obligations may also increase the risk of errors or delays in our financial and SEC reporting, and we may not be able to effectively manage these additional requirements, which could adversely affect investor confidence and the [added] market price of our [added] common stock.
Cite this change
"large accelerated filer, we are subject to enhanced reporting, internal control, and compliance obligations, including auditor attestation of internal control over financial reporting, additional reporting obligations regarding executive compensation"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
05·Merged·Item 1A › Risks Related to Our Business › Our gross margins may decline due to a variety of factors, which could negatively impact our results of operations and our financial condition.
Summary · quote-checked
Added disclosure that customer warrants reduce revenue and gross margins, with timing and magnitude potentially causing fluctuations in reported results.
The paragraph adds a new warrant-related accounting treatment, obligation, and source of gross-margin and results-of-operations volatility, changing the disclosed risk substance.
Why the model ranked it here
The disclosure introduces customer-warrant accounting that reduces reported revenue and margins and can create volatility in reported results.
Filing text · FY2024 10-K · filed Feb 14, 2025
In addition, we maintain an inventory of our products at various stages of production and in finished goods inventory. We hold these inventories in anticipation of customer orders. If those customer orders do not materialize in a timely[removed] manner, we may have excess or obsolete [removed] inventory which we would have to reserve or write-down, and our gross margins would be adversely affected.
Filing text · FY2025 10-K · filed Feb 20, 2026
In addition, we maintain an inventory of our products at various stages of production and in finished goods inventory. We hold these inventories in anticipation of customer orders. If those customer orders do not materialize in a timely[added] manner, we may have excess or obsolete [added] inventory, which we would have to reserve or write-down, and our gross margins would be adversely affected.[added] In addition, for customers that we issue warrants, we recognize the related grant date fair value of the warrants as a reduction of revenue for each sales transaction in proportion to total expected cumulative sales volume resulting in achievement of the vesting conditions, which reduces the reported gross profit and gross margin in the periods the related revenue is recognized. The timing and magnitude of these charges may vary and could cause fluctuations in our reported gross margins and results of operations.
Cite this change
"In addition, for customers that we issue warrants, we recognize the related grant date fair value of the warrants as a reduction of revenue for each sales transaction in proportion to total expected cumulative sales volume resulting in achievement of the vesting conditions, which reduces the reported gross profit and gross margin in the periods the related revenue is recognized. The timing and magnitude of these charges may vary and could cause fluctuations in our reported gross margins and results of operations."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
06·Changed·Item 1A › Risks Related to Our Business › Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.
Summary · quote-checked
The cybersecurity risk disclosure adds potential liabilities, regulatory orders, notification duties, sanctions, customer requirements, contractual exposure, and insurance limitations.
These additions introduce new obligations, consequences, counterparties’ requirements, and limitations on protection, substantively expanding the disclosed cybersecurity exposure.
Why the model ranked it here
The cybersecurity risk now includes potentially material liabilities, regulatory orders, customer requirements, and limits on insurance protection.
Filing text · FY2024 10-K · filed Feb 14, 2025
U.S. and foreign regulators have also increased their focus on cybersecurity vulnerabilities and risks. Compliance with laws and regulations concerning privacy, cybersecurity, data governance, and data protection could result in significant expense, and any failure to comply could result in proceedings against us by regulatory authorities or other third parties. Such proceedings could result in (among other things) unfavorable publicity, damage to our reputation, possible financial obligations for liabilities, and government orders to implement additional protective measures or adopt new protocols, which could result in additional material expense. Further, customers and third-party manufacturing partners increasingly demand rigorous contractual, certification, and audit provisions regarding privacy, cybersecurity, data governance, data protection, confidentiality, and intellectual property, which may also increase our overall compliance burden.
Filing text · FY2025 10-K · filed Feb 20, 2026
U.S. and foreign regulators have also increased their focus on cybersecurity vulnerabilities and risks. Compliance with laws and regulations concerning privacy, cybersecurity, data governance, and data protection could result in significant expense, and any failure to comply could result in proceedings against us by regulatory authorities or other third parties. Such proceedings could result in (among other things) unfavorable publicity, damage to our reputation, possible[added] financial obligations for liabilities, and government orders to implement additional protective measures or adopt new protocols, which could result in additional material expense. Moreover, we may be required to make legal notifications to affected individuals, disclosures to investors, and subject to fines and other sanctions resulting from any related breaches of applicable data privacy laws and regulations. Further, customers and third-party manufacturing partners increasingly demand rigorous contractual, certification, and audit provisions regarding privacy, cybersecurity, data governance, data protection, confidentiality, and intellectual property, which may also increase our overall compliance burden. Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our privacy and data security obligations. Further, any cyber liability insurance that we maintain may not provide adequate coverage against potential liabilities related to any experienced cybersecurity incident or breach.
Cite this change
"financial obligations for liabilities, and government orders to implement additional protective measures or adopt new protocols, which could result in additional material expense."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
07·Changed·Item 1A › Risks Related to Our Business › We previously identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. Although these material weaknesses have been remediated, if we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.
Summary · quote-checked
The disclosure shifts from ongoing remediation of material weaknesses to completed implementation, while retaining risks of additional weaknesses and control failures.
Remediation status and modality changed from ongoing and potentially unsuccessful to completed, altering the stated internal-control risk and related reporting obligations.
Why the model ranked it here
Management now states that previously identified material weaknesses have been remediated, changing the status of the company’s internal-control risk while retaining the possibility of further deficiencies.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] While we are designing and implementing new controls and measures to remediate [removed] these material weaknesses, [removed] the measures we are taking may not be sufficient to [removed] remediate the material weaknesses or avoid the identification of additional material weaknesses in the future. Any failure to [removed] remediate our material weaknesses and to implement and maintain effective internal control over financial reporting also could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we [removed] will eventually be required to include in our periodic reports [removed] that will be filed with the SEC. Ineffective disclosure controls and procedures and internal control over financial reporting could also result in errors in our consolidated financial statements that could result in a restatement of our financial statements and could cause us to fail to meet our periodic reporting obligations, any of which could diminish investor confidence in us and cause a decline in the price of our common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the Nasdaq Global Select Market ("Nasdaq").
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] We have designed and implemented new controls and measures to remediate [added] our previously identified material weaknesses, [added] and these measures may not be sufficient to avoid the identification of additional material weaknesses in the future. Any failure to implement and maintain effective internal control over financial reporting also could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we [added] are required to include in our periodic reports with the SEC. Ineffective disclosure controls and procedures and internal control over financial reporting could also result in errors in our consolidated financial statements that could result in a restatement of our financial statements and could cause us to fail to meet our periodic reporting obligations, any of which could diminish investor confidence in us and cause a decline in the price of our common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the Nasdaq Global Select Market ("Nasdaq").
Cite this change
"We have designed and implemented new controls and measures to remediate our previously identified material weaknesses, and these measures may not be sufficient to avoid the identification of additional material weaknesses in the future."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
08·Changed·Item 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.
Summary · quote-checked
The disclosure shifts from customer and government-imposed compliance burdens to failures to comply and resulting proceedings, penalties, business changes, and adverse effects.
The risk’s stated triggers and consequences substantively change, adding noncompliance exposure, governmental actions, significant penalties, reputational harm, and operational compliance costs.
Why the model ranked it here
The disclosure now emphasizes consequences of compliance failures, including proceedings, penalties, reputational harm, and required changes to business practices.
Filing text · FY2024 10-K · filed Feb 14, 2025
U.S. and foreign regulators have also increased their focus on cybersecurity vulnerabilities and risks. Compliance with laws and regulations concerning privacy, cybersecurity, data governance, and data protection could result in significant expense, and any failure to comply could result in proceedings against us by regulatory authorities or other third parties. Such proceedings could result in (among other things) unfavorable publicity, damage to our reputation, possible [removed] financial obligations for liabilities, and government orders to implement additional protective measures or adopt new protocols, which could result in [removed] additional material expense. Further, customers and third-party manufacturing partners increasingly demand rigorous contractual, certification, and audit provisions regarding privacy, cybersecurity, data governance, data protection, confidentiality, and intellectual property, which may also increase our overall compliance burden.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] Any failure, or perceived failure, by us to comply with applicable data protection or other laws, or with regulatory obligations or industry standards in our customer contracts, could result in [added] damage to our reputation, proceedings, or actions against us by governmental entities or others, subject us to significant fines, penalties, judgments, and negative publicity, require us to change our business practices as well as increase the costs and complexity of compliance. Any of the foregoing could have a material adverse effect on our business, financial condition, and results of operations.
Cite this change
"Any failure, or perceived failure, by us to comply with applicable data protection or other laws, or with regulatory obligations or industry standards in our customer contracts, could result in damage to our reputation, proceedings, or actions against us by governmental entities or others, subject us to significant fines, penalties, judgments, and negative publicity, require us to change our business practices as well as increase the costs and complexity of compliance. Any of the foregoing could have a material adverse effect on our business, financial condition, and results of operations."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
09·Changed·Item 1A › Risks Related to Our Business › Our operating results are impacted by wide fluctuations of supply and demand in the industry.
Summary · quote-checked
The disclosure shifts from risks involving material availability, quality, and cost pass-through to manufacturing partners’ lack of future capacity assurances.
This changes the stated supply dependency and risk mechanism, introducing an explicit absence of capacity assurances rather than only describing potential sourcing and cost consequences.
Why the model ranked it here
Manufacturing partners no longer provide assurances of future capacity, making the company’s supply dependency more explicit and consequential.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our third-party manufacturing partners may also extend lead times, limit supplies, place products on allocation, or increase prices that could lead to interruption of supply or increased demand in the industry. For example, the supply of these materials may be negatively impacted by increased trade tensions between the United States and its trading partners, particularly the People's Republic of China. Moreover, TSMC has increased and may increase in the future the wafer prices we pay. Our products are incorporated into complex devices and systems, which creates supply chain cross-dependencies. Due to these cross dependencies, any supply chain disruptions could impact the demand for our products in [removed] the short term. In the event that we cannot obtain sufficient quantities of materials in a timely manner or at reasonable prices from third-party manufacturing [removed] partners, the quality of the material deteriorates or we are not able to pass on higher manufacturing costs to our customers, our business, financial condition, and results of operations could be adversely impacted.
Filing text · FY2025 10-K · filed Feb 20, 2026
Further, any upturn in the semiconductor industry could result in increased competition for access to third-party manufacturing partners. We are dependent on the availability of this capacity to manufacture and assemble our products, [added] and our third-party manufacturing [added] partners have not provided assurances that adequate capacity will be available to us in the future.
Cite this change
"and our third-party manufacturing partners have not provided assurances that adequate capacity will be available to us in the future."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
10·Changed·Item 1A › Risks Related to Our Business › We may experience difficulties demonstrating to customers the value of our new products or newer generations of our existing products.
Summary · quote-checked
The disclosure replaces a general adverse-effects statement with specific risks involving customer system needs and adoption of newer products.
The current text adds substantive customer-adoption and product-fit risks, while the prior text stated resulting revenue and business impacts; this is more than rephrasing.
Filing text · FY2024 10-K · filed Feb 14, 2025
As we develop and introduce new products or new generations of our existing products, we face the risk that our new products do not meet the needs of our customers' next generation systems and applications or that our customers may forego adopting one or more newer generations of our existing products. Regardless of the improved features or superior performance of the newer generations of our existing products, customers may be unwilling to adopt our new products due to design or pricing constraints, among other reasons. Even if customers choose to adopt our new products or new generations of our existing products, they may be slow to do so, which may result in certain of our products selling more frequently than other products for sustained periods of time. For example, most of our historical sales have been for our Aries Smart DSP Retimer product family. Because of the extensive time and resources that we invest in researching and developing new products and new generations of our existing products, if we are unable to sell new products or new generations of our existing products, [removed] our revenue could decline and our business, financial condition, and results of operations would be negatively affected.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] As we develop and introduce new products or new generations of our existing products, [added] we face the risk that our new products do not meet the needs of our customers' next generation systems and applications or that our customers may forego adopting one or more newer generations of our existing products. Regardless of the improved features or superior performance of the newer generations of our existing products, customers may be unwilling to adopt our new products due to design or pricing constraints, among other reasons. Even if customers choose to adopt our new products or new generations of our existing products, they may be slow to do so, which may result in certain of our products selling more frequently than other products for sustained periods of time. For example, most of our historical sales have been for our Aries Smart DSP Retimer product family. Because of the extensive time and resources that we invest in researching and developing new products and new generations of our existing products, if we are unable to sell new products or new generations of our existing products, our revenue could decline and our business, financial condition, and results of operations would be negatively affected.
Cite this change
"As we develop and introduce new products or new generations of our existing products, we face the risk that our new products do not meet the needs of our customers' next generation systems and applications or that our customers may forego adopting one or more newer generations of our existing products. Regardless of the improved features or superior"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
11·Changed·Item 1A › Risk Factors Summary › Risks Related to Our Business
Summary · quote-checked
The disclosure was condensed, removing statements about industry changes, manufacturing partners, customers, and product demand dependencies.
The current text retains the economic-conditions risk but omits substantive dependencies and drivers described in the prior paragraph, so the disclosed risk scope changed.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our business, financial condition, and results of operations [removed] have in the past and may in the future vary based on changes in our industry, as well as [removed] the impact of the global economy on our third-party manufacturing partners and customers. Our results of operations currently depend, in part, on the demand for our products, which in turn are influenced by the amount of business that our customers conduct. To the extent that weak or volatile economic conditions, including due to a pandemic or health epidemic, labor shortages, supply chain disruptions, inflation, geopolitical developments (such as the implementation of, or changes to or further expansions of, trade sanctions, export restrictions, tariffs, and embargoes), deterioration of the financial services industry, and other events outside of our control, result in a reduced volume of business for our customers and prospective customers, demand for, and use of, our products has in the past and may in the future decline.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] • Our business, financial condition, and results of operations [added] could be adversely affected by worldwide economic conditions, as well as [added] political and economic conditions in the countries in which we conduct business;
Cite this change
"• Our business, financial condition, and results of operations could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which we conduct business;"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
12·Changed·Item 1A › Risks Related to Our Business › A substantial portion of our revenue is driven by a limited number of our end customers, and the loss of, or a significant reduction in, demand from one or a few of our top end customers would adversely affect our operations and financial condition.
Summary · quote-checked
The risk discussion shifts from losing customers or failing to attract them to customer competition, adoption of competitors, and effects on forecasted sales.
The paragraph adds substantive customer-dependency risks: end customers may develop competing products or adopt competitors’ solutions, affecting forecasted sales and results.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] The loss of a top end customer, a reduction in sales to any top end customer, or our inability to attract new end customers [removed] could impact our revenue and materially and adversely affect our results of [removed] operations.
Filing text · FY2025 10-K · filed Feb 20, 2026
End customer relationships often require us to develop new products that may involve significant technological and design challenges, and our end customers frequently place considerable pressure on us to meet tight development schedules. Accordingly, we may have to devote a substantial amount of our resources to our strategic relationships, which could detract from or delay our completion of other important development projects. Delays in development could impair [added] our relationships with our end customers and negatively impact forecasted sales of the products under development. Moreover, it is possible that our end customers [added] may develop their own products that may compete with our solutions, or adopt a competitor's solution for products that they currently buy from us. If that happens, our sales would be adversely impacted and our business, financial condition, and results of [added] operations would be materially and adversely affected.
Cite this change
"our relationships with our end customers and negatively impact forecasted sales of the products under development. Moreover, it is possible that our end customers may develop their own products that may compete with our solutions, or adopt a competitor's solution for products that they currently buy from us. If that happens, our sales would be adversely impacted and our business, financial condition, and results of operations would be materially and adversely affected."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
13·Changed·Item 1A › Risks Related to Our Business › Regulatory authorities in jurisdictions into or from which we ship our products or import supplies could levy fines, restrict or delay our ability to export products or import supplies, or increase costs associated with the manufacture or transfer of products.
Summary · quote-checked
Added specific sanctioned countries and described administrative cost and business-partner limitations from regulatory changes.
The disclosure now names jurisdictions and adds operational-cost and counterparty limitations, expanding the substance of the regulatory-sanctions risk beyond the prior adverse-effect statement.
Filing text · FY2024 10-K · filed Feb 14, 2025
Further, determination by a government that we have failed to comply with trade sanctions, investment, anti-bribery, or other regulations can result in penalties which may include denial of export privileges, fines, penalties, and seizure of products, or loss of reputation, any of which could have a material adverse effect on our business, sales, and earnings. A change in laws and regulations could restrict our ability to transfer product to previously permitted countries, customers, distributors or others. For example, the U.S. Commerce Department imposes and periodically revises restrictions on advanced computing ICs, computer commodities that contain such ICs, as well as on certain semiconductor manufacturing items, and expands controls on transactions involving items for supercomputer and semiconductors and manufacturing end-uses. In October 2023, the U.S. Commerce Department issued proposed rules updating the October 2022 rule to seek additional export restrictions for certain semiconductors and related manufacturing equipment, and it is expected the U.S. Commerce Department will continue to revise such regulations in the future. The Export Administration Regulations also effectively prohibits sales of items for a "military end use," to a "military end-user," or for a "military intelligence end-user," or end-use to certain countries, such as Belarus, Burma, Cambodia, Cuba, China, Iran, North Korea, Russia, Syria, and Venezuela. Any of the foregoing changes could adversely impact our operational costs due to the administrative impacts of complying with these regulations and may limit those with whom we conduct business. Any one or more of these sanctions, future sanctions, a change in laws or regulations, or a prohibition on shipment of our products to significant customers could have a material adverse effect on our business, financial condition, and results of operations.
Filing text · FY2025 10-K · filed Feb 20, 2026
Further, determination by a government that we have failed to comply with trade sanctions, investment, anti-bribery, or other regulations can result in penalties that may include denial of export privileges, fines, penalties, and seizure of products, or loss of reputation, any of which could have a material adverse effect on our business, sales, and earnings. A change in laws and regulations could restrict our ability to transfer product to previously permitted countries, customers, distributors or others. For example, the U.S. Commerce Department imposes and periodically revises restrictions on advanced computing ICs, computer commodities that contain such ICs, as well as on certain semiconductor manufacturing items, and expands controls on transactions involving items for supercomputer and semiconductors and manufacturing end-uses. In October 2023, the U.S. Commerce Department issued proposed rules updating the October 2022 rule to seek additional export restrictions for certain semiconductors and related manufacturing equipment, and it is expected the U.S. Commerce Department will continue to revise such regulations in the future. The Export Administration Regulations also effectively prohibits sales of items for a "military end use," to a "military end-user," or for a "military intelligence end- [added] user," or end-use to certain countries, such as Belarus, Burma, Cambodia, Cuba, China, Iran, North Korea, Russia, Syria, and Venezuela. Any of the foregoing changes could adversely impact our operational costs due to the administrative impacts of complying with these regulations and may limit those with whom we conduct business. Any one or more of these sanctions, future sanctions, a change in laws or regulations, or a prohibition on shipment of our products to significant customers could have a material adverse effect on our business, financial condition, and results of operations.
Cite this change
"user," or end-use to certain countries, such as Belarus, Burma, Cambodia, Cuba, China, Iran, North Korea, Russia, Syria, and Venezuela. Any of the foregoing changes could adversely impact our operational costs due to the administrative impacts of complying with these regulations and may limit those with whom we conduct business."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
14·Changed·Item 1A › Risks Related to Our Business › We have rapidly grown as a business in dynamic and rapidly evolving markets, and we may have difficulty accurately predicting our future revenue for the purpose of appropriately budgeting and adjusting our expenses.
Summary · quote-checked
The risk description changed from limited operating history and experience to rapid business growth as a factor impairing revenue forecasting.
This changes the stated basis of the forecasting risk: limited experience was removed and rapid growth was added, altering the substance rather than merely rephrasing it.
Filing text · FY2024 10-K · filed Feb 14, 2025
We [removed] were established in October 2017. Our limited operating experience, a dynamic and rapidly evolving market in which we sell our products, our dependence on a limited number of customers, as well as numerous other factors beyond our control, could impede our ability to forecast quarterly and annual revenue accurately. As a result, we could experience budgeting and cash flow management problems, unexpected fluctuations in our results of operations and other challenges, any of which could make it difficult for us to maintain profitability and could increase the volatility of the market price of our common stock.
Filing text · FY2025 10-K · filed Feb 20, 2026
We [added] have a rapidly growing business, a dynamic and rapidly evolving market in which we sell our products, our dependence on a limited number of customers, as well as numerous other factors beyond our control, could impede our ability to forecast quarterly and annual revenue accurately. As a result, we could experience budgeting and cash flow management problems, unexpected fluctuations in our results of operations and other challenges, any of which could make it difficult for us to maintain profitability and could increase the volatility of the market price of our common stock.
Cite this change
"We have a rapidly growing business, a dynamic and rapidly evolving market in which we sell our products, our dependence on a limited number of customers, as well as numerous other factors beyond our control, could impede our ability to forecast quarterly and annual revenue accurately."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
15·Changed·Item 1A › Risk Factors Summary › Risks Related to Our Business
Summary · quote-checked
The risk description changed from limited operating history to rapid growth in dynamic and rapidly evolving markets.
The paragraph now identifies rapid growth and market dynamics, rather than limited operating history, as the basis for difficulty forecasting revenue; the disclosed risk premise changed.
Filing text · FY2024 10-K · filed Feb 14, 2025
• We have [removed] a limited operating history, and we may have difficulty accurately predicting our future revenue for the purpose of appropriately budgeting and adjusting our expenses;
Filing text · FY2025 10-K · filed Feb 20, 2026
• We have [added] rapidly grown as a business in dynamic and rapidly evolving markets, and we may have difficulty accurately predicting our future revenue for the purpose of appropriately budgeting and adjusting our expenses;
Cite this change
"We have rapidly grown as a business in dynamic and rapidly evolving markets, and we may have difficulty accurately predicting our future revenue for the purpose of appropriately budgeting and adjusting our expenses;"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
16·Changed·Item 1A › Risks Related to Our Business › We are in the process of transitioning to a new enterprise resource planning system ("ERP"), and our assessment of readiness, prioritization of resources, and any delays or difficulties associated with the design, implementation, or post-implementation use of our new ERP system could adversely impact our business, financial condition, and results of operations.
Summary · quote-checked
ERP transition language changed from a planned engagement to ongoing evaluation involving readiness, resources, prioritization, and timeline assessment.
The disclosure changes the implementation status and adds substantive discussion of organizational readiness, resource requirements, initiative prioritization, and continued timeline evaluation.
Filing text · FY2024 10-K · filed Feb 14, 2025
We rely on information systems to manage our business, summarize our operating and financial results, and provide timely information to our management. We [removed] plan to engage in the design and implementation of a new ERP system beginning in 2025. This process is a complex project with broad scope, in which we will invest significant financial and human capital. Despite our efforts, we may experience delays, unexpected costs, or other difficulties throughout the design and implementation process. Further, although we plan to conduct extensive testing in an effort to ensure that the new ERP system is operating as intended, post-implementation disruptions to or difficulties in use of the new ERP could require us to incur additional costs, or could impair, among other things, our ability to record sales, process transactions, collect receivables, and produce timely and accurate historical and forecasted financial information, which could adversely impact our business, financial condition, and results of operations. Additionally, if the new ERP system does not ultimately operate as intended, the effectiveness of our internal control over financial reporting could be harmed.
Filing text · FY2025 10-K · filed Feb 20, 2026
We rely on information systems to manage our business, summarize our operating and financial results, and provide timely information to our management. We [added] have been evaluating the design and implementation of a new ERP system[added] as part of our efforts to enhance and scale our operational and financial systems. As our evaluation has progressed, we have continued to assess our organizational readiness, resource requirements, and overall prioritization of initiatives before proceeding with implementation. As a result, we are continuing to evaluate the appropriate timeline for the design and implementation of a new ERP system and may adjust the scope, timing, or approach to implementation based on our ongoing assessments. This process is a complex project with broad scope, in which we have and will continue to invest significant financial and human capital. Despite our efforts, we may experience delays, unexpected costs, or other difficulties throughout the design and implementation process. Further, although we will need to conduct extensive testing in an effort to ensure that the new ERP system is operating as intended, post-implementation disruptions to or difficulties in use of any such system could require us to incur additional costs, or could impair, among other things, our ability to record sales, process transactions, collect receivables, and produce timely and accurate historical and forecasted financial information, which could adversely impact our business, financial condition, and results of operations. Additionally, if the ERP system we implement does not ultimately operate as intended, the effectiveness of our internal control over financial reporting could be harmed.
Cite this change
"We have been evaluating the design and implementation of a new ERP system as part of our efforts to enhance and scale our operational and financial systems."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
17·Changed·Item 1A › Risks Related to the Ownership of Our Common Stock › Our second amended and restated bylaws designate specific courts as the sole and exclusive forum for certain disputes that may be initiated by our stockholders, which could limit our stockholders' ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.
Summary · quote-checked
The paragraph no longer describes the Delaware and federal forum provisions governing stockholder disputes.
Removing these provisions eliminates disclosure of designated courts and exclusive federal jurisdiction for certain Securities Act and Exchange Act claims, changing the stated litigation-risk substance.
Filing text · FY2024 10-K · filed Feb 14, 2025
Pursuant to our second amended and restated bylaws, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for state law claims for (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a claim of, or a claim based on, a breach of a fiduciary duty owed by any current or former director, officer or other employee of ours to us or our stockholders; (iii) any action asserting a claim pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our second amended and restated bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the [removed] State of Delaware; or (iv) any action asserting a claim governed by the internal affairs doctrine (collectively, the "Delaware Forum Provision"). The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Our second amended and restated bylaws further provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act or the Exchange Act and the respective rules and regulations promulgated thereunder (the "Federal Forum Provision"). In addition, our second amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.
Filing text · FY2025 10-K · filed Feb 20, 2026
Pursuant to our second amended and restated bylaws, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for state law claims for (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a claim of, or a claim based on, a breach of a fiduciary duty owed by any current or former director, officer or other employee of ours to us or our stockholders; (iii) any action asserting a claim pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our second amended and restated bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; or (iv) any action asserting a claim governed by the internal affairs doctrine (collectively, the "Delaware Forum Provision"). The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Our second amended and restated bylaws further provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act or the Exchange Act and the respective rules and regulations promulgated thereunder (the "Federal Forum Provision"). In addition, our second amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.
Cite this change
"In addition, our second amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
18·Changed·Item 1A › Risks Related to our Intellectual Property › Any potential dispute involving patents or other intellectual property could affect our customers, which could trigger our indemnification obligations to them and result in substantial expense to us.
Summary · quote-checked
Added disclosure that maximum loss clauses may create substantial liability and that customer litigation could trigger indemnification obligations.
The change adds distinct liability exposure and specifies litigation against customers as a trigger for indemnification, substantively expanding the disclosed risk.
Filing text · FY2024 10-K · filed Feb 14, 2025
In any potential dispute involving patents or other intellectual property, our customers could also become the target of litigation. Our agreements with customers generally include indemnification or other provisions under which we agree to indemnify or otherwise be liable to them for losses suffered or incurred as a result of third-party claims of intellectual property infringement. Large indemnity payments could harm our business, financial condition, and results of operations. From time to time, customers require us to indemnify or otherwise be liable to them for breach of confidentiality or failure to implement adequate security measures with respect to their intellectual property and trade secrets. Although we normally contractually limit our liability with respect to such obligations, certain of our customer agreements may not include maximum loss clauses, which may result in substantial liability. Any litigation against our customers could trigger indemnification obligations under some of our agreements, which could result in substantial expense to us, and which could materially and adversely affect our financial results.
Filing text · FY2025 10-K · filed Feb 20, 2026
In any potential dispute involving patents or other intellectual property, our customers could also become the target of litigation. Our agreements with customers generally include indemnification or other provisions under which we agree to indemnify or otherwise be liable to them for losses suffered or incurred as a result of third-party claims of intellectual property infringement. Large indemnity payments could harm our business, financial condition, and results of operations. From time to time, customers require us to indemnify or otherwise be liable to them for breach of confidentiality or failure to implement adequate security measures with respect to their intellectual property and trade secrets. Although we normally contractually limit our liability with respect to such obligations, certain of our customer agreements may not include [added] maximum loss clauses, which may result in substantial liability. Any litigation against our customers could trigger indemnification obligations under some of our agreements, which could result in substantial expense to us, and which could materially and adversely affect our financial results.
Cite this change
"maximum loss clauses, which may result in substantial liability. Any litigation against our customers could trigger"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
19·Changed·Item 1A › Risks Related to Our Business › We previously identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. Although these material weaknesses have been remediated, if we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.
Summary · quote-checked
The disclosure changes from anticipated Section 404 compliance and possible weaknesses to current compliance, remediated weaknesses, and specific future control risks.
The paragraph changes the company’s regulatory and attestation status, states that weaknesses were remediated, and adds risks involving scaling, a new ERP system, and foreign subsidiaries.
Filing text · FY2024 10-K · filed Feb 14, 2025
We are [removed] not currently required to comply with the SEC rules that implement Section 404 of the [removed] Sarbanes- Oxley Act and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. [removed] As a public company, we are required to [removed] provide an annual management report on the effectiveness of our internal control over financial [removed] reporting commencing with our second annual report on Form 10-K. Our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal control over financial reporting until we are no longer considered an emerging growth company. At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could harm our business and could cause a decline in the trading price of our common stock.
Filing text · FY2025 10-K · filed Feb 20, 2026
We are [added] subject to Section 404(a) and (b) of the [added] Sarbanes-Oxley Act, which requires us to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. [added] In addition, our independent registered public accounting firm is required to [added] formally attest to the effectiveness of our internal control over financial [added] reporting. Maintaining effective disclosure controls and procedures and effective internal controls over financial reporting are necessary for us to produce reliable financial statements and disclosure reports. While we have remediated previously identified material weaknesses, we cannot assure you that additional material weaknesses will not arise in the future, particularly as we continue to scale our operations, integrate new systems and processes such as a new enterprise resource planning system, and as certain of our foreign subsidiaries, which historically have not been subject to full SOX-based testing due to their size and scope, grow or otherwise become material and require expanded internal control design, documentation, and testing. Any failure to maintain effective disclosure controls and internal control over financial reporting could harm our business and could cause a decline in the trading price of our common stock.
Cite this change
"We are subject to Section 404(a) and (b) of the Sarbanes-Oxley Act, which requires us to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
20·Changed·Item 1A › Risks Related to Our Business › Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.
Summary · quote-checked
The cybersecurity risk now addresses AI-enhanced attacks and insider threats while removing discussion of geopolitical cyber conflicts and breach consequences.
The disclosure changes the described threat sources and omits previously stated consequences and exposures, adding substantive cybersecurity risks rather than merely rephrasing the text.
Filing text · FY2024 10-K · filed Feb 14, 2025
Cyber-attacks are increasing in number and sophistication, are well-financed, in some cases supported by state actors, and are designed to not only attack, but also to evade [removed] detection. Since the techniques used to obtain unauthorized access to systems and data, or to otherwise sabotage them, change frequently and are often not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. [removed] Geopolitical instability may increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful security breaches, data breaches, or other unauthorized access to our [removed] information systems or the systems of our third-party [removed] service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties. Despite our internal controls and investment in security measures, we have in the past, and may again in the future, be subject to cyber-attacks or unauthorized network intrusions. These events, should they occur, could disrupt our business and result in, among other things, unfavorable publicity, damage to our reputation, loss of our trade secrets and other competitive information, litigation by affected parties and possible financial obligations for liabilities and damages related to the theft or misuse of such information, significant remediation costs, disruption of key business operations, and significant diversion of our resources, legal notifications and disclosures, as well as fines and other sanctions resulting from any related breaches of data privacy laws and regulations (such as the CCPA), any of which could have a material adverse effect on our business, profitability, and financial condition. In addition, despite our internal controls and processes, malicious code, and cybersecurity vulnerabilities in our products and services may expose our customers to cyberattacks and other security risks, which may result in claims, regulatory action, or reputational damage. While we may be entitled to damages if an adverse event arises from our third-party service providers' failure to perform under their agreements with us, any award may be insufficient to cover the actual costs incurred by us and, as a result of a service provider's failure to perform, we may be unable to collect any damages.
Filing text · FY2025 10-K · filed Feb 20, 2026
Cyber-attacks are increasing in number and sophistication, are well-financed, in some cases supported by state actors, and are designed to not only attack, but also to evade [added] detection, and are being facilitated or enhanced by evolving technologies, including AI. Since the techniques used to obtain unauthorized access to systems and data, or to otherwise sabotage them, change frequently and are often not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. [added] Attempts to disrupt or gain unauthorized access to our [added] and our third-party [added] vendors' information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or facilitated by evolving technologies such as AI. Geopolitical instability may also increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful cybersecurity incidents, data breaches, or other unauthorized access to our information systems or the systems of our third-party service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or the misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties.
Cite this change
"Attempts to disrupt or gain unauthorized access to our and our third-party vendors' information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or facilitated by evolving technologies"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
21·Changed·Item 1A › Risks Related to our Intellectual Property › We rely on third-party technologies for the development of our products and our inability to use such technologies in the future would harm our ability to remain competitive.
Summary · quote-checked
Added disclosure that inability to use or license third-party technology may leave inadequate alternatives and harm product offerings and competitiveness.
The addition introduces a specific dependency consequence—lack of timely adequate alternatives—and expressly links it to offering products and remaining competitive, substantively expanding the risk.
Filing text · FY2024 10-K · filed Feb 14, 2025
We rely on third parties for technologies that are integrated into our products. If we are unable to continue to use or license these technologies on reasonable terms, or if these technologies become unreliable, unavailable or fail to operate properly, we may not be able to secure adequate alternatives in a timely manner or at all, and our ability to offer our products and remain competitive in our market would be harmed. In addition, even if we are unable to successfully license technology from third-parties to develop future products, we may not be able to develop such products in a timely manner or at all. The operation or security of our products could be impaired if errors or other defects occur in the third-party technologies we use, and it may be more difficult for us to correct any such errors and defects in a timely manner, if at all, because the development and maintenance of these technologies is not within our control. Any impairment of the technologies or of our relationship with these third parties could harm our business.
Filing text · FY2025 10-K · filed Feb 20, 2026
We rely on third parties for technologies that are integrated into our products. If we are unable to continue to use or license these technologies on reasonable terms, or if these technologies become unreliable, unavailable or fail to operate [added] properly, we may not be able to secure adequate alternatives in a timely manner or at all, and our ability to offer our products and remain competitive in our market would be harmed. In addition, even if we are unable to successfully license technology from third-parties to develop future products, we may not be able to develop such products in a timely manner or at all. The operation or security of our products could be impaired if errors or other defects occur in the third-party technologies we use, and it may be more difficult for us to correct any such errors and defects in a timely manner, if at all, because the development and maintenance of these technologies is not within our control. Any impairment of the technologies or of our relationship with these third parties could harm our business.
Cite this change
"properly, we may not be able to secure adequate alternatives in a timely manner or at all, and our ability to offer our products and remain competitive in our market would be harmed."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
22·Changed·Item 1A › Risks Related to Our Business › A pandemic, epidemic, or outbreak of an infectious disease may materially and adversely affect our business and our financial results.
Summary · quote-checked
The disclosure shifts from specific COVID-19 effects and macroeconomic aftermath to broader potential disruptions from pandemics and public health crises.
Specific realized COVID-19 impacts, supply shortages, liquidity effects and macroeconomic consequences were removed, while broader potential effects on activity, labor markets, supply chains and stakeholders were added.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our business could be adversely affected by health crises in regions where we operate or otherwise do business. [removed] For example, the policies and regulations implemented in response to the outbreak of COVID-19 had a significant impact, both directly and indirectly, on businesses and commerce and the global supply chain for semiconductors. Although restrictions have generally been lifted, additional indirect effects such as supply shortages continue to impact segments of the global economy. Other global health concerns could also result in social, economic, and labor instability in the countries in which we or the third parties with whom we engage operate. The conditions caused by the COVID-19 pandemic and its aftermath as well as macroeconomic conditions have caused diminished liquidity and credit availability, declines in customer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability, and any future health crisis may have a similar impact.
Filing text · FY2025 10-K · filed Feb 20, 2026
Our business could be adversely affected by [added] pandemics, epidemics, outbreaks of infectious diseases or other public health crises in regions where we operate or otherwise do business. [added] Such events could disrupt global and regional economic activity, labor markets, and supply chains, including those applicable to the semiconductor industry, and could adversely affect our employees, customers, suppliers and other business partners.
Cite this change
"Such events could disrupt global and regional economic activity, labor markets, and supply chains, including those applicable to the semiconductor industry, and could adversely affect our employees, customers, suppliers and other business partners."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
23·Changed·Item 1A › Risks Related to Our Business › A pandemic, epidemic, or outbreak of an infectious disease may materially and adversely affect our business and our financial results.
Summary · quote-checked
The disclosure removes COVID-19-specific historical impacts and reframes the potential effects of future public health crises on operations and customers.
The risk description shifts from documented COVID-19 effects and customer purchasing impacts to a broader public-health-crisis risk and materially impaired operations, changing the substance of the disclosure.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] Our operations have in the past been negatively affected by a range of external factors related to the effects of the COVID-19 pandemic that are not within our control. We may also be negatively affected by a future pandemic, epidemic, outbreak of an infectious disease or public health crisis. In the past many cities, counties, states, and [removed] even countries have previously imposed or may impose a wide range of restrictions on the physical movement of our employees, partners, and [removed] customers to limit the spread of COVID-19, including physical distancing, travel bans and restrictions, closure of non-essential business, quarantines, work-from-home directives, and shelter-in-place orders. These measures have previously caused, and may cause in the future, business slowdowns or shutdowns in affected areas, both regionally and worldwide. If future pandemics, epidemics or other global health crises have a substantial impact on the productivity of our employees and partners, or [removed] a continued substantial impact on the ability of our employees to execute responsibilities, or a continued and substantial impact on the ability of our customers to purchase our products, our results of [removed] operations, and overall financial performance may be harmed.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] Public health crises may result in cities, counties, states, and [added] countries imposing a wide range of restrictions on the physical movement of our employees, partners, and [added] customers, including physical distancing, travel bans and restrictions, closure of non-essential business, quarantines, work-from-home directives, and shelter-in-place orders. These measures have previously caused, and may cause in the future, business slowdowns or shutdowns in affected areas, both regionally and worldwide. If future pandemics, epidemics or other global health crises have a substantial impact on the productivity of our employees and partners, or [added] materially impair our ability to operate our business or our customers' ability to purchase our products, our results of [added] operations and overall financial performance may be harmed.
Cite this change
"Public health crises may result in cities, counties, states, and countries imposing a wide range of restrictions on the physical movement of our employees, partners, and customers, including physical distancing, travel bans and restrictions, closure of non-essential business, quarantines, work-from-home directives, and shelter-in-place orders."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
24·Changed·Item 1A › Risks Related to Our Business › Our business, financial condition, and results of operations could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which we conduct business.
Summary · quote-checked
The risk discussion now identifies industry changes, third-party manufacturing partners, government shutdowns, and international conflicts as factors affecting results and demand.
These additions introduce or expand identified dependencies and events tied to business performance, rather than merely rephrasing the existing economic-conditions risk.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our business, financial condition, and results of operations have in the past and may in the future vary based on changes in our industry, as well as the impact of the global economy on our third-party manufacturing partners and customers. Our results of operations currently depend, in part, on the demand for our products, which in turn are influenced by the amount of business that our customers conduct. To the extent that weak or volatile economic conditions, including due to a pandemic or health epidemic, labor shortages, supply chain disruptions, inflation, geopolitical developments (such as the implementation of, or changes to or further expansions of, trade sanctions, export restrictions, tariffs, and embargoes), deterioration of the financial services industry, and other events outside of our control, result in a reduced volume of business for our customers and prospective customers, demand for, and use of, our products has in the past and may in the future decline.
Filing text · FY2025 10-K · filed Feb 20, 2026
[added] Our business, financial condition, and results of operations have in the past and may in the future vary based on changes in our industry, as well as the impact of the global economy on our third-party manufacturing partners and customers. Our results of operations currently depend, in part, on the demand for our products, which in turn are influenced by the amount of business that our customers conduct. To the extent that weak or volatile economic conditions, including due to a pandemic or health epidemic, labor shortages, supply chain disruptions, inflation, [added] government shutdowns, geopolitical developments (such as [added] international conflicts and the implementation of, or changes to or further expansions of, trade sanctions, export restrictions, tariffs, and embargoes), deterioration of the financial services industry, and other events outside of our control, result in a reduced volume of business for our customers and prospective customers, demand for, and use of, our products has in the past and may in the future decline.
Cite this change
"Our business, financial condition, and results of operations have in the past and may in the future vary based on changes in our industry, as well as the impact of the global economy on our third-party manufacturing partners and customers."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
25·Changed·Item 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.
Summary · quote-checked
The disclosure adds specific personal-data processing obligations and a GDPR-related EEA and UK compliance risk, while removing broader generic privacy-law language.
The paragraph introduces a named regulatory regime, jurisdictions, compliance costs, and potential fines, litigation, and reputational harm tied to European activities, changing the disclosed risk.
Filing text · FY2024 10-K · filed Feb 14, 2025
For example, the [removed] California Consumer Privacy Act of 2018 (the "CCPA") as amended by the California Privacy Rights Act, affords California residents broad privacy rights and protections, and provides for civil penalties for certain violations. Numerous additional states have passed and others have proposed and may in the future pass comprehensive state privacy laws that may impose additional obligations on our business. [removed] Data privacy laws and regulations are constantly evolving and can be subject to significant change and/or interpretive application. Varying and evolving jurisdictional requirements could increase the costs and complexity of our compliance efforts and require changes to how we conduct our business. Violations of applicable data privacy laws can result in significant penalties. Any failure, or perceived failure, by us to comply with applicable data protection or other laws could result in proceedings, or actions against us by governmental entities or others, subject us to [removed] significant fines, penalties, judgments, and negative publicity, require us to change our business practices, increase the costs and complexity of compliance, and could have a material adverse effect on our business, financial condition, and results of operations.
Filing text · FY2025 10-K · filed Feb 20, 2026
For example, the [added] CCPA as amended by the California Privacy Rights Act, affords California residents broad privacy rights and protections, [added] imposes specific obligations with respect to the processing and storage of personal data and provides for civil penalties for certain violations. Numerous additional states have passed and others have proposed and may in the future pass comprehensive state privacy laws that may impose additional obligations on our business. [added] Also, if we collect and process personal data regarding individuals in the European Economic Area ("EEA") or the UK, we may be subject to the GDPR in this report unless specified otherwise. Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost of doing business or require us to [added] change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our potential European activities.
Cite this change
"Also, if we collect and process personal data regarding individuals in the European Economic Area ("EEA") or the UK, we may be subject to the GDPR in this report unless specified otherwise."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
26·Changed·Item 1A › Risks Related to Our Business › We are in the process of transitioning to a new enterprise resource planning system ("ERP"), and our assessment of readiness, prioritization of resources, and any delays or difficulties associated with the design, implementation, or post-implementation use of our new ERP system could adversely impact our business, financial condition, and results of operations.
Summary · quote-checked
ERP transition is described as underway, with possible adjustments to scope, timing, and approach and investment already made.
The disclosure shifts from planned future implementation to an ongoing transition, adds flexibility to adjust implementation, and states investment has occurred, substantively changing the ERP execution-risk disclosure.
Filing text · FY2024 10-K · filed Feb 14, 2025
We rely on information systems to manage our business, summarize our operating and financial results, and provide timely information to our management. We plan to engage in the design and implementation of a new ERP system [removed] beginning in 2025. This process is a complex project with broad scope, in which we [removed] will invest significant financial and human capital. Despite our efforts, we may experience delays, unexpected costs, or other difficulties throughout the design and implementation process. Further, although we [removed] plan to conduct extensive testing in an effort to ensure that the new ERP system is operating as intended, post-implementation disruptions to or difficulties in use of [removed] the new ERP could require us to incur additional costs, or could impair, among other things, our ability to record sales, process transactions, collect receivables, and produce timely and accurate historical and forecasted financial information, which could adversely impact our business, financial condition, and results of operations. Additionally, if the [removed] new ERP system does not ultimately operate as intended, the effectiveness of our internal control over financial reporting could be harmed.
Filing text · FY2025 10-K · filed Feb 20, 2026
We rely on information systems to manage our business, summarize our operating and financial results, and provide timely information to our management. We have been evaluating the design and implementation of a new ERP system as part of our efforts to enhance and scale our operational and financial systems. As our evaluation has progressed, we have continued to assess our organizational readiness, resource requirements, and overall prioritization of initiatives before proceeding with implementation. As a result, we are continuing to evaluate the appropriate timeline for the design and [added] implementation of a new ERP system and may adjust the scope, timing, or approach to implementation based on our ongoing assessments. This process is a complex project with broad scope, in which we [added] have and will continue to invest significant financial and human capital. Despite our efforts, we may experience delays, unexpected costs, or other difficulties throughout the design and implementation process. Further, although we [added] will need to conduct extensive testing in an effort to ensure that the new ERP system is operating as intended, post-implementation disruptions to or difficulties in use of [added] any such system could require us to incur additional costs, or could impair, among other things, our ability to record sales, process transactions, collect receivables, and produce timely and accurate historical and forecasted financial information, which could adversely impact our business, financial condition, and results of operations. Additionally, if the ERP system [added] we implement does not ultimately operate as intended, the effectiveness of our internal control over financial reporting could be harmed.
Cite this change
"implementation of a new ERP system and may adjust the scope, timing, or approach to implementation based on our ongoing assessments."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
27·Changed·Item 1A › Risks Related to Our Business › We may pursue acquisitions, investments, joint ventures, and dispositions, which could adversely affect our results of operations, and any acquisitions we do make could disrupt our business and harm our financial condition.
Summary · quote-checked
The risk disclosure expands from acquisitions alone to investments, joint ventures, or acquisitions and their integration.
The added activities are newly brought within the stated risks and uncertainties, expanding the scope of the disclosed business risk beyond a wording-only revision.
Filing text · FY2024 10-K · filed Feb 14, 2025
Any acquisitions we may undertake and their integration involve risks and uncertainties, such as:
Filing text · FY2025 10-K · filed Feb 20, 2026
Any [added] investments, joint ventures or acquisitions we may undertake and their integration involve risks and uncertainties, such as:
Cite this change
"Any investments, joint ventures or acquisitions we may undertake and their integration involve risks and uncertainties, such as:"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
28·Changed·Item 1A › Risks Related to Our Business › A substantial portion of our revenue is driven by a limited number of our end customers, and the loss of, or a significant reduction in, demand from one or a few of our top end customers would adversely affect our operations and financial condition.
Summary · quote-checked
Added explicit disclosure that losing or reducing sales to a top customer, or failing to attract new customers, could materially harm results.
The added sentence introduces and emphasizes specific customer-loss, sales-reduction, and customer-acquisition risks with a material adverse effect on results of operations.
Filing text · FY2024 10-K · filed Feb 14, 2025
In addition, to attract new customers or retain existing end customers, we may offer (in some cases through distributors) certain customers favorable prices for our products. In that event, our revenue and gross margins may decline.
Filing text · FY2025 10-K · filed Feb 20, 2026
In addition, to attract new customers or retain existing end customers, we may offer (in some cases through distributors) certain customers favorable prices for our products. In that event, our revenue and gross margins may decline.[added] The loss of a top end customer, a reduction in sales to any top end customer, or our inability to attract new end customers could impact our revenue and materially and adversely affect our results of operations.
Cite this change
"The loss of a top end customer, a reduction in sales to any top end customer, or our inability to attract new end customers could impact our revenue and materially and adversely affect our results of operations."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
29·Changed·Item 1A › Risks Related to Our Business › Changes in current or future laws or regulations or the imposition of new laws or regulations by federal or state agencies or foreign governments could impair our ability to compete in international markets, or subject us to criminal penalties or significant fines, which may adversely affect our business and reputation.
Summary · quote-checked
The paragraph removes disclosures about liability for intermediary and employee misconduct and limitations of the anti-corruption compliance program.
The removed text narrows the stated scope of potential liability and eliminates an explicit compliance-program limitation, changing the disclosed corruption-related risk.
Filing text · FY2024 10-K · filed Feb 14, 2025
In addition, in the future we may use third parties to conduct business on our behalf abroad. We or such future third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities, and we can be held liable for the corrupt or other illegal activities of such future third-party[removed] intermediaries and our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. We have implemented an anti-corruption compliance program, but cannot guarantee that all our employees and agents, as well as those companies we outsource certain of our business operations to, will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. Any violation of the FCPA, other applicable anti-corruption laws, or anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, prosecutions, loss of export privileges, suspension or debarment from U.S. government contracts, substantial diversion of management's attention, significant legal fees and fines, settlements, damages, severe criminal or civil sanctions, penalties or injunctions against us, our officers, or our employees, disgorgement of profits, and other sanctions, enforcement actions, and remedial measures, and prohibitions on the conduct of our business, any of which could have a materially adverse effect on our reputation, business, trading price, results of operations, financial condition, and prospects.
Filing text · FY2025 10-K · filed Feb 20, 2026
In addition, in the future we may use third parties to conduct business on our behalf abroad. We or such future third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities, and we can be held liable for the corrupt or other illegal activities of such future third-party intermediaries and our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. We have implemented an anti-corruption compliance program, but cannot guarantee that all our employees and agents, as well as those companies we outsource certain of our business operations to, will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. Any violation of the FCPA, other applicable anti-corruption laws, or anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, prosecutions, loss of export privileges, suspension or debarment from U.S. government contracts, substantial diversion of management's attention, significant legal fees and fines, settlements, damages, severe criminal or civil sanctions, penalties or injunctions against us, our officers, or our employees, disgorgement of profits, and other sanctions, enforcement actions, and remedial measures, and prohibitions on the conduct of our business, any of which could have a materially adverse effect on our reputation, business, trading price, results of operations, financial condition, and prospects.
Cite this change
"In addition, in the future we may use third parties to conduct business on our behalf abroad. We or such future third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities, and we can be held liable for the corrupt or other illegal activities of such future third-party"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
30·Changed·Item 1A › Risks Related to the Ownership of Our Common Stock › Our issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans, or otherwise will dilute all other stockholders and could negatively affect our results of operations.
Summary · quote-checked
Updated stock-based compensation expense and replaced RSU-specific vesting disclosures with a broader statement about equity awards.
The paragraph removes IPO-related vesting mechanics and changes the scope and qualification from RSUs only to equity awards primarily subject to time-based vesting, beyond a routine annual update.
Filing text · FY2024 10-K · filed Feb 14, 2025
Any additional grants of equity awards under our stock incentive plans will also increase stock-based compensation expense and negatively affect our results of operations. For example, during the year ended December 31, [removed] 2024, stock-based compensation expense was [removed] $234.6 million. Commencing in June 2022, we began granting RSUs to employees. These RSUs vest upon the satisfaction of both a time condition and a liquidity event condition. In March 2024, we completed our IPO, as a result of which the liquidity event condition was satisfied. Subsequent to the IPO, any unvested RSUs subject to both the time vesting condition and liquidity event vesting condition will vest as the time vesting condition is met over the remaining period. As a public company, our [removed] RSUs are only subject to time-based vesting, and accordingly we expect to continue to incur stock-based compensation expense as these [removed] RSUs vest.
Filing text · FY2025 10-K · filed Feb 20, 2026
Any additional grants of equity awards under our stock incentive plans will also increase stock-based compensation expense and negatively affect our results of operations. For example, during the year ended December 31, [added] 2025, stock-based compensation expense was [added] $160.0 million. As a public company, our [added] equity awards are primarily subject to time-based vesting, and accordingly we expect to continue to incur stock-based compensation expense as these [added] awards vest.
Cite this change
"As a public company, our equity awards are primarily subject to time-based vesting, and accordingly we expect to continue to incur stock-based compensation expense as these awards vest."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
31·Changed·Item 1A › Risks Related to Our Business › Changes in current or future laws or regulations or the imposition of new laws or regulations by federal or state agencies or foreign governments could impair our ability to compete in international markets, or subject us to criminal penalties or significant fines, which may adversely affect our business and reputation.
Summary · quote-checked
The disclosure expands anti-corruption risks to unauthorized conduct by intermediaries, employees, contractors, partners, agents, and outsourced business operators.
It adds responsibility for third-party and outsourced activities and describes an anti-corruption compliance program, substantively expanding the stated legal and compliance exposure.
Filing text · FY2024 10-K · filed Feb 14, 2025
In addition, in the future we may use third parties to conduct business on our behalf abroad. We or such future third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities, and we can be held liable for the corrupt or other illegal activities of such future third-party intermediaries and our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. We have implemented an anti-corruption compliance program, but cannot guarantee that all our employees and agents, as well as those companies we outsource certain of our business operations to, will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. Any violation of the FCPA, other applicable anti-corruption laws, or anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, prosecutions, loss of export privileges, suspension or debarment from U.S. government contracts, substantial diversion of management's attention, significant legal fees and fines, settlements, damages, severe criminal or civil sanctions, penalties or injunctions against us, our officers, or our employees, disgorgement of profits, and other sanctions, enforcement actions, and remedial measures, and prohibitions on the conduct of our business, any of which could have a materially adverse effect on our reputation, business, trading price, results of operations, financial condition, and prospects.
Filing text · FY2025 10-K · filed Feb 20, 2026
In addition, in the future we may use third parties to conduct business on our behalf abroad. We or such future third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities, and we can be held liable for the corrupt or other illegal activities of such future third-party [added] intermediaries and our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. We have implemented an anti-corruption compliance program, but cannot guarantee that all our employees and agents, as well as those companies we outsource certain of our [added] business operations to, will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. Any violation of the FCPA, other applicable anti-corruption laws, or anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, prosecutions, loss of export privileges, suspension or debarment from U.S. government contracts, substantial diversion of management's attention, significant legal fees and fines, settlements, damages, severe criminal or civil sanctions, penalties or injunctions against us, our officers, or our employees, disgorgement of profits, and other sanctions, enforcement actions, and remedial measures, and prohibitions on the conduct of our business, any of which could have a materially adverse effect on our reputation, business, trading price, results of operations, financial condition, and prospects.
Cite this change
"intermediaries and our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. We have implemented an anti-corruption compliance program, but cannot guarantee that all our employees and agents, as well as those companies we outsource certain"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
32·Changed·Item 1A › Risks Related to our Intellectual Property › We rely on third-party technologies for the development of our products and our inability to use such technologies in the future would harm our ability to remain competitive.
Summary · quote-checked
The disclosure removes the risk that failed third-party technologies could prevent timely alternatives and harm product offerings and competitiveness.
A substantive consequence of technology unavailability was removed, changing the stated impact of the third-party technology dependency.
Filing text · FY2024 10-K · filed Feb 14, 2025
We rely on third parties for technologies that are integrated into our products. If we are unable to continue to use or license these technologies on reasonable terms, or if these technologies become unreliable, unavailable or fail to operate[removed] properly, we may not be able to secure adequate alternatives in a timely manner or at all, and our ability to offer our products and remain competitive in our market would be harmed. In addition, even if we are unable to successfully license technology from third-parties to develop future products, we may not be able to develop such products in a timely manner or at all. The operation or security of our products could be impaired if errors or other defects occur in the third-party technologies we use, and it may be more difficult for us to correct any such errors and defects in a timely manner, if at all, because the development and maintenance of these technologies is not within our control. Any impairment of the technologies or of our relationship with these third parties could harm our business.
Filing text · FY2025 10-K · filed Feb 20, 2026
We rely on third parties for technologies that are integrated into our products. If we are unable to continue to use or license these technologies on reasonable terms, or if these technologies become unreliable, unavailable or fail to operate properly, we may not be able to secure adequate alternatives in a timely manner or at all, and our ability to offer our products and remain competitive in our market would be harmed. In addition, even if we are unable to successfully license technology from third-parties to develop future products, we may not be able to develop such products in a timely manner or at all. The operation or security of our products could be impaired if errors or other defects occur in the third-party technologies we use, and it may be more difficult for us to correct any such errors and defects in a timely manner, if at all, because the development and maintenance of these technologies is not within our control. Any impairment of the technologies or of our relationship with these third parties could harm our business.
Cite this change
"If we are unable to continue to use or license these technologies on reasonable terms, or if these technologies become unreliable, unavailable or fail to operate"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
33·Changed·Item 1A › Risks Related to Our Business › Adverse changes in the political, regulatory, and economic policies of governments in connection with trade with China and Chinese customers have reduced the demand for our products and damaged our business.
Summary · quote-checked
The paragraph removes risks involving unreliable suppliers and indirect system impacts, while adding risks from restricted-person lists and fluid U.S. and Chinese tariff policies.
The disclosure changes the identified regulatory and commercial exposures, adding potential sales restrictions and tariff-driven demand effects while removing previously stated supplier-reliability and indirect-impact risks.
Filing text · FY2024 10-K · filed Feb 14, 2025
Regulatory activity, such as tariffs, export controls, economic sanctions, and restrictions on investment and data transfers as well as vigorous enforcement of U.S. export controls and economic sanctions laws have in the past and may continue to materially limit our ability to make sales to our customers in China, which has in the past and may continue to harm our results of operations, reputation, and financial condition. Due to the U.S. government restricting sales to certain customers in China, sales to some of our customers may require licenses in order for us to export our products; however, there can be no assurances that requests for licenses will be approved by the U.S. government. [removed] Moreover, concerns that U.S. companies may not be reliable suppliers as a result of these and other actions has caused, and may in the future cause, some of our customers in China to amass large inventories of our products well in advance of need or caused some of our customers to replace our products in favor of products from other suppliers. Additionally, the Chinese government adopted a law with respect to unreliable suppliers. Any designation as an unreliable supplier may have an adverse impact on our business and operations. In addition, there may be indirect impacts to our business that we cannot easily quantify such as the fact that some of our other customers' systems may also be impacted by export restrictions.
Filing text · FY2025 10-K · filed Feb 20, 2026
Regulatory activity, such as tariffs, export controls, economic sanctions, and restrictions on investment and data transfers as well as vigorous enforcement of U.S. export controls and economic sanctions laws have in the past and may continue to materially limit our ability to make sales to our customers in China, which has in the past and may continue to harm our results of operations, reputation, and financial condition. Due to the U.S. government restricting sales to certain customers in China, sales to some of our customers may require licenses in order for us to export our products; however, there can be no assurances that requests for licenses will be approved by the U.S. government. [added] Further, augmentation of restricted or prohibited persons lists maintained by the U.S. government could reduce our ability to sell to certain customers. Fluid tariff policies of both the U.S. and Chinese governments may reduce demand for our products and could increase input costs. Moreover, concerns that U.S. companies may not be reliable suppliers as a result of these and other actions has caused, and may in the future cause, some of our customers in China to amass large inventories of our products well in advance of need or caused some of our customers to replace our products in favor of products from other suppliers. Additionally, the Chinese government adopted a law with respect to unreliable suppliers. Any designation as an unreliable supplier may have an adverse impact on our business and operations. Recent U.S. government restrictions on investments into China by U.S. persons and regarding access by Chinese persons to certain personal data relating to U.S. persons could hinder our Chinese operations. In addition, there may be indirect impacts to our business that we cannot easily quantify such as the fact that some of our other customers' systems may also be impacted by export restrictions.
Cite this change
"Further, augmentation of restricted or prohibited persons lists maintained by the U.S. government could reduce our ability to sell to certain customers."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
34·Changed·Item 1A › General Risk Factors › We have incurred, and will continue to incur, increased costs as a result of operating as a public company, and our management is required to devote substantial time to support compliance with our public company responsibilities and corporate governance practices.
Summary · quote-checked
The disclosure replaces the expected end of emerging growth company status with the company’s recent transition to large accelerated filer status.
The filing identifies a different reporting-status transition as the reason public-company costs are expected to increase, changing the stated compliance context.
Filing text · FY2024 10-K · filed Feb 14, 2025
As a public company, we have incurred, and will continue to incur, significant finance, legal, accounting, and other expenses, including director and officer liability insurance, that we did not incur as a private company, and which we expect to further increase [removed] after we are no longer an "emerging growth company." The Sarbanes-Oxley Act, the Dodd- Frank Act, stock exchange listing requirements, the reporting requirements of the Exchange Act and other applicable securities rules and regulations impose various requirements on public companies in the United States. [removed] Our management and other personnel devote a substantial amount of time to support compliance with these requirements. Moreover, these rules and regulations have increased, and will continue to increase, our legal and financial compliance costs and make some activities more time-consuming and costly. We cannot predict or estimate the amount of additional costs we will continue to incur as a public company or the specific timing of such costs.
Filing text · FY2025 10-K · filed Feb 20, 2026
As a public company, we have incurred, and will continue to incur, significant finance, legal, accounting, and other expenses, including director and officer liability insurance, that we did not incur as a private company, and which we expect to further increase [added] following our recent transition to large accelerated filer status. The Sarbanes-Oxley Act, the Dodd- Frank Act, stock exchange listing requirements, the reporting requirements of the Exchange Act and other applicable securities rules and regulations impose various requirements on public companies in the United States. [added] As a large accelerated filer, we are subject to enhanced reporting, internal control, and compliance obligations, including auditor attestation of internal control over financial reporting, additional reporting obligations regarding executive compensation, and the requirement to hold nonbinding advisory votes on executive compensation, and our management and other personnel devote a substantial amount of time to support compliance with these requirements. Moreover, these rules and regulations have increased, and will continue to increase, our legal and financial compliance costs and make certain activities more time-consuming and costly. We cannot predict the amount or timing of these additional costs that we will incur as a public company, and the resulting strain on management resources could adversely affect our results of operations and financial condition. These enhanced obligations may also increase the risk of errors or delays in our financial and SEC reporting, and we may not be able to effectively manage these additional requirements, which could adversely affect investor confidence and the market price of our common stock.
Cite this change
"As a public company, we have incurred, and will continue to incur, significant finance, legal, accounting, and other expenses, including director and officer liability insurance, that we did not incur as a private company, and which we expect to further increase following our recent transition to large accelerated filer status."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
35·Changed·Item 1A › Risks Related to Our Business › A substantial portion of our revenue is driven by a limited number of our end customers, and the loss of, or a significant reduction in, demand from one or a few of our top end customers would adversely affect our operations and financial condition.
Summary · quote-checked
The paragraph removes disclosures about customer relationship damage, competing products, competitor adoption, and resulting adverse effects on sales and financial condition.
The removed text eliminates substantive customer-concentration and competitive risks, not merely wording or formatting.
Filing text · FY2024 10-K · filed Feb 14, 2025
End customer relationships often require us to develop new products that may involve significant technological and design challenges, and our end customers frequently place considerable pressure on us to meet tight development schedules. Accordingly, we may have to devote a substantial amount of our resources to our strategic relationships, which could detract from or delay our completion of other important development projects. Delays in development could impair[removed] our relationships with our end customers and negatively impact forecasted sales of the products under development. Moreover, it is possible that our end customers may develop their own products that may compete with our solutions, or adopt a competitor's solution for products that they currently buy from us. If that happens, our sales would be adversely impacted and our business, financial condition, and results of operations would be materially and adversely affected.
Filing text · FY2025 10-K · filed Feb 20, 2026
End customer relationships often require us to develop new products that may involve significant technological and design challenges, and our end customers frequently place considerable pressure on us to meet tight development schedules. Accordingly, we may have to devote a substantial amount of our resources to our strategic relationships, which could detract from or delay our completion of other important development projects. Delays in development could impair our relationships with our end customers and negatively impact forecasted sales of the products under development. Moreover, it is possible that our end customers may develop their own products that may compete with our solutions, or adopt a competitor's solution for products that they currently buy from us. If that happens, our sales would be adversely impacted and our business, financial condition, and results of operations would be materially and adversely affected.
Cite this change
"Delays in development could impair"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
36·Changed·Item 1A › Risks Related to Our Business › Changes in existing tax laws, tax rules, or tax practices may adversely affect our financial results.
Summary · quote-checked
The tax risk now specifically cites the One Big Beautiful Bill Act enacted into law on July 4, 2025.
A newly named, enacted law is tied to the tax-law risk, adding a concrete event beyond the prior general disclosure.
Filing text · FY2024 10-K · filed Feb 14, 2025
The rules governing U.S. federal, state, and local and non-U.S. taxation are constantly under review by persons involved in the legislative process, the Internal Revenue Service, the U.S. Treasury Department, and other taxing authorities. Changes to tax laws or tax rulings, or changes in interpretations of existing laws (which changes may have retroactive application), could adversely affect us or holders of our common stock. These changes could subject us to additional income-based taxes and non-income taxes (such as payroll, sales, use, value-added, digital tax, net worth, property, and goods and services taxes), which in turn could materially affect our financial position and results of operations. Additionally, new, changed, modified, or newly interpreted or applied tax laws could increase our customers' and our compliance, operating, and other costs, as well as the costs of our products. In recent years, many such changes have been made, and changes are likely to continue to occur in the future. As we expand the scale of our business activities, any changes in the U.S. and non-U.S. taxation of such activities may increase our effective tax rate and harm our business, financial condition, and results of operations.
Filing text · FY2025 10-K · filed Feb 20, 2026
The rules governing U.S. federal, state, and local and non-U.S. taxation are constantly under review by persons involved in the legislative process, the Internal Revenue Service, the U.S. Treasury Department, and other taxing authorities. Changes to tax laws or tax rulings, [added] such as the One Big Beautiful Bill Act enacted into law on July 4, 2025, or changes in interpretations of existing laws (which changes may have retroactive application), could adversely affect us or holders of our common stock. These changes could subject us to additional income-based taxes and non-income taxes (such as payroll, sales, use, value-added, digital tax, net worth, property, and goods and services taxes), which in turn could materially affect our financial position and results of operations. Additionally, new, changed, modified, or newly interpreted or applied tax laws could increase our customers' and our compliance, operating, and other costs, as well as the costs of our products. In recent years, many such changes have been made, and changes are likely to continue to occur in the future. As we expand the scale of our business activities, any changes in the U.S. and non-U.S. taxation of such activities may increase our effective tax rate and harm our business, financial condition, and results of operations.
Cite this change
"Changes to tax laws or tax rulings, such as the One Big Beautiful Bill Act enacted into law on July 4, 2025, or changes in interpretations of existing laws (which changes may have retroactive application), could adversely affect us or holders of our common stock."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
37·Changed·Item 1A › Risks Related to the Ownership of Our Common Stock › Our second amended and restated bylaws designate specific courts as the sole and exclusive forum for certain disputes that may be initiated by our stockholders, which could limit our stockholders' ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.
Summary · quote-checked
Added an internal-affairs forum provision and specified federal district courts as the exclusive forum for Securities Act and Exchange Act claims.
The disclosure adds substantive forum-selection obligations and exclusions affecting where stockholder claims may be brought, changing the litigation risk described.
Filing text · FY2024 10-K · filed Feb 14, 2025
Pursuant to our second amended and restated bylaws, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for state law claims for (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a claim of, or a claim based on, a breach of a fiduciary duty owed by any current or former director, officer or other employee of ours to us or our stockholders; (iii) any action asserting a claim pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our second amended and restated bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; or (iv) any action asserting a claim governed by the internal affairs doctrine (collectively, the "Delaware Forum Provision"). The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Our second amended and restated bylaws further provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act or the Exchange Act and the respective rules and regulations promulgated thereunder (the "Federal Forum Provision"). In addition, our second amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.
Filing text · FY2025 10-K · filed Feb 20, 2026
Pursuant to our second amended and restated bylaws, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for state law claims for (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a claim of, or a claim based on, a breach of a fiduciary duty owed by any current or former director, officer or other employee of ours to us or our stockholders; (iii) any action asserting a claim pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our second amended and restated bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the[added] State of Delaware; or (iv) any action asserting a claim governed by the internal affairs doctrine (collectively, the "Delaware Forum Provision"). The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Our second amended and restated bylaws further provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act or the Exchange Act and the respective rules and regulations promulgated thereunder (the "Federal Forum Provision"). In addition, our second amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.
Cite this change
"State of Delaware; or (iv) any action asserting a claim governed by the internal affairs doctrine (collectively, the "Delaware Forum Provision"). The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Our second amended and restated bylaws further provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act or the Exchange Act and the respective rules and regulations promulgated thereunder (the "Federal Forum Provision")."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
38·Changed·Item 1A › Risk Factors Summary › Risks Related to Our Business
Summary · quote-checked
The disclosure changes from a history of generating net losses to a limited history of generating net income.
The statement changes the company’s reported profitability history and therefore alters the substance of the profitability risk, beyond a stylistic rephrasing.
Filing text · FY2024 10-K · filed Feb 14, 2025
• We have a history of generating net [removed] losses, and if we are unable to achieve adequate revenue growth while our expenses increase, we may not maintain profitability in the future;
Filing text · FY2025 10-K · filed Feb 20, 2026
• We have a [added] limited history of generating net [added] income, and if we are unable to achieve adequate revenue growth while our expenses increase, we may not maintain profitability in the future;
Cite this change
"• We have a limited history of generating net income, and if we are unable to achieve adequate revenue growth while our expenses increase, we may not maintain profitability in the future;"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
39·Changed·Item 1A › Risks Related to Our Business › We may experience difficulties demonstrating to customers the value of our new products or newer generations of our existing products.
Summary · quote-checked
The paragraph removes specific customer-adoption risks and adds that inability to sell new products could reduce revenue and harm business results.
The disclosure changes both the stated risk mechanisms and consequences, replacing customer needs and adoption concerns with explicit revenue, business, financial-condition, and results-of-operations effects.
Filing text · FY2024 10-K · filed Feb 14, 2025
[removed] As we develop and introduce new products or new generations of our existing products, we face the risk that our new products do not meet the needs of our customers' next generation systems and applications or that our customers may forego adopting one or more newer generations of our existing products. Regardless of the improved features or superior performance of the newer generations of our existing products, customers may be unwilling to adopt our new products due to design or pricing constraints, among other reasons. Even if customers choose to adopt our new products or new generations of our existing products, they may be slow to do so, which may result in certain of our products selling more frequently than other products for sustained periods of time. For example, most of our historical sales have been for our Aries Smart DSP Retimer product family. Because of the extensive time and resources that we invest in researching and developing new products and new generations of our existing products, if we are unable to sell new products or new generations of our existing products, our revenue could decline and our business, financial condition, and results of operations would be negatively affected.
Filing text · FY2025 10-K · filed Feb 20, 2026
As we develop and introduce new products or new generations of our existing products, we face the risk that our new products do not meet the needs of our customers' next generation systems and applications or that our customers may forego adopting one or more newer generations of our existing products. Regardless of the improved features or superior performance of the newer generations of our existing products, customers may be unwilling to adopt our new products due to design or pricing constraints, among other reasons. Even if customers choose to adopt our new products or new generations of our existing products, they may be slow to do so, which may result in certain of our products selling more frequently than other products for sustained periods of time. For example, most of our historical sales have been for our Aries Smart DSP Retimer product family. Because of the extensive time and resources that we invest in researching and developing new products and new generations of our existing products, if we are unable to sell new products or new[added] generations of our existing products, our revenue could decline and our business, financial condition, and results of operations would be negatively affected.
Cite this change
"generations of our existing products, our revenue could decline and our business, financial condition, and results of operations would be negatively affected."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
40·Changed·Item 1A › Risks Related to Our Business › We may pursue acquisitions, investments, joint ventures, and dispositions, which could adversely affect our results of operations, and any acquisitions we do make could disrupt our business and harm our financial condition.
Summary · quote-checked
The disclosure expands the potential transactions from acquisitions to investments in companies, businesses and/or assets.
Investments introduce an additional transaction type and broaden the identified scope of activities that may affect operating or financial results.
Filing text · FY2024 10-K · filed Feb 14, 2025
We have in the past, and may in the future choose to acquire [removed] companies that are complementary to our business, including for the purpose of expanding our new product design capacity, introducing new design, market, or application skills, enhancing, and expanding our existing product lines or grow the number of engineers. We cannot forecast the number, timing or size of future acquisitions, or the effect that any such acquisitions might have on our operating or financial results.
Filing text · FY2025 10-K · filed Feb 20, 2026
We have in the past, and may in the future choose to acquire [added] or make investments in companies, businesses and/or assets that are complementary to our business, including for the purpose of expanding our new product design capacity, introducing new design, market, or application skills, enhancing, and expanding our existing product lines or grow the number of engineers. We cannot forecast the number, timing or size of future [added] investments or acquisitions, or the effect that any such [added] investments or acquisitions might have on our operating or financial results.
Cite this change
"We have in the past, and may in the future choose to acquire or make investments in companies, businesses and/or assets that are complementary to our business, including for the purpose of expanding our new product design capacity, introducing new design, market, or application skills, enhancing, and expanding our existing product lines or grow the number of engineers."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
41·Changed·Item 1A › Risks Related to Our Business › Our operating results are impacted by wide fluctuations of supply and demand in the industry.
Summary · quote-checked
Removed the statement that third-party manufacturing partners had not assured adequate future capacity.
The deletion removes a substantive disclosure about manufacturing-capacity uncertainty and supplier assurances, changing the stated supply dependency risk.
Filing text · FY2024 10-K · filed Feb 14, 2025
Further, any upturn in the semiconductor industry could result in increased competition for access to [removed] third- party manufacturing partners. We are dependent on the availability of this capacity to manufacture and assemble our products,[removed] and our third-party manufacturing partners have not provided assurances that adequate capacity will be available to us in the future.
Filing text · FY2025 10-K · filed Feb 20, 2026
Further, any upturn in the semiconductor industry could result in increased competition for access to [added] third-party manufacturing partners. We are dependent on the availability of this capacity to manufacture and assemble our products, and our third-party manufacturing partners have not provided assurances that adequate capacity will be available to us in the future.
Cite this change
"Further, any upturn in the semiconductor industry could result in increased competition for access to third-party manufacturing partners. We are dependent on the availability of this capacity to manufacture and assemble our products,"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
42·Changed·Item 1A › Risks Related to Our Business › Regulatory authorities in jurisdictions into or from which we ship our products or import supplies could levy fines, restrict or delay our ability to export products or import supplies, or increase costs associated with the manufacture or transfer of products.
Summary · quote-checked
Added disclosure that tariffs on semiconductors and critical minerals, and tariff increases by other nations, could reduce demand and increase input costs.
The added sentences identify specific tariff exposures and additional effects on product demand and input costs, substantively expanding the disclosed trade-related risks.
Filing text · FY2024 10-K · filed Feb 14, 2025
The United States and other countries have levied tariffs and taxes on certain goods, implemented trade restrictions, and introduced national security protection policies. Trade tensions between the United States and China, which escalated in 2018, have continued and include the United States increasing tariffs on Chinese origin goods and China increasing tariffs on U.S. origin goods. Increases on tariffs on Chinese-origin goods may intensify pricing pressure on our products and negatively impact our operating results. Increased tariffs on our customers' systems could adversely impact their sales, and increased tariffs on our products in comparison to those of our competitors could each result in lower demand for our products.
Filing text · FY2025 10-K · filed Feb 20, 2026
The United States and other countries have levied tariffs and taxes on certain goods, implemented trade restrictions, and introduced national security protection policies. Trade tensions between the United States and China, which escalated in 2018, have continued and include the United States increasing tariffs on Chinese origin goods and China increasing tariffs on U.S. origin goods. Increases on tariffs on Chinese-origin goods may intensify pricing pressure on our products and negatively impact our operating results. Increased tariffs on our customers' systems could adversely impact their sales, and increased tariffs on our products in comparison to those of our competitors could each result in lower demand for our products.[added] U.S. tariffs, including those on semiconductors, could reduce demand for our products. Additionally, U.S. tariffs, including those on critical minerals, could increase our input costs. Tariff increases by other nations could similarly negatively affect demand for our products and could increase input costs.
Cite this change
"U.S. tariffs, including those on semiconductors, could reduce demand for our products. Additionally, U.S. tariffs, including those on critical minerals, could increase our input costs. Tariff increases by other nations could similarly negatively affect demand for our products and could increase input costs."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
43·Changed·Item 1A › Risks Related to Our Business › The adoption, use, and commercialization of AI technology, and the continued rapid pace of developments in the AI field, are inherently uncertain. Failure by our customers to continue to adopt or invest in AI infrastructure to support AI use cases in their systems, or our ability to keep up with evolving AI infrastructure requirements, could have a material adverse effect on our business, financial condition, and results of operations.
Summary · quote-checked
The AI regulation risk was expanded to cover general purpose AI models, potential fines, additional jurisdictions, and evolving guidance and enforcement, while removing some prior impacts.
The disclosure adds new regulatory scope, penalties, jurisdictions, and enforcement risks, and removes prior statements about required resources and customer demand effects; these substantively change the stated obligations and exposures.
Filing text · FY2024 10-K · filed Feb 14, 2025
Additionally, we expect to see increasing government and supranational regulation related to [removed] artificial intelligence use and ethics, which may also significantly increase the burden and cost of research, development, and compliance in this area. For example, the EU's Artificial Intelligence [removed] Act, or the EU AI Act, - the world's first comprehensive AI law - entered into force in [removed] June 2024 and, with some exceptions, [removed] become effective 24 months thereafter. [removed] This legislation imposes significant obligations on providers and deployers of high risk [removed] artificial intelligence systems, and encourages providers and deployers [removed] of artificial intelligence systems to account for EU ethical principles [removed] in their development and use of these systems. If we develop or use AI systems that are governed by the EU AI Act, it may necessitate ensuring higher standards of data quality, transparency, and human oversight, as well as adhering to specific and potentially burdensome and costly ethical, accountability, and administrative requirements. [removed] Significant resources will be required to design, develop, test and maintain our products to help ensure that artificial intelligence is implemented and deployed in accordance with applicable law and regulation and in a socially responsible manner and to minimize any real or perceived unintended harmful impacts. Our customers may also become subject to [removed] such upcoming AI regulations, which could cause a delay or impediment to the commercialization of AI technology and could lead to a decrease in demand for our customers' AI systems, and may adversely affect our business, financial condition, and results of operations.
Filing text · FY2025 10-K · filed Feb 20, 2026
Additionally, we expect to see increasing government and supranational [added] legislation and regulation related to [added] AI use and ethics, which may also significantly increase the burden and cost of research, development, and compliance in this area. For example, the EU's Artificial Intelligence [added] Act ("EU AI Act"), entered into force in [added] August 2024 and, with some exceptions, [added] becomes effective 24 months thereafter. [added] As enacted, the EU AI Act imposes significant obligations on providers and deployers of high risk [added] AI systems and general purpose AI models and encourages providers and deployers to account for EU ethical principles [added] when developing and using AI technology. The scope of requirements depends on judicial interpretations and forthcoming legislative amendments, and non-compliance can lead to significant fines. If we develop or use AI systems that are governed by the EU AI Act, it may necessitate ensuring higher standards of data quality, transparency, and human oversight, as well as adhering to specific and potentially burdensome and costly ethical, accountability, and administrative requirements. [added] In addition, we may become subject to [added] similar or additional legislation or requirements in the United States or other jurisdictions, as well as evolving regulatory guidance and enforcement under existing laws.
Cite this change
"As enacted, the EU AI Act imposes significant obligations on providers and deployers of high risk AI systems and general purpose AI models and encourages providers and deployers to account for EU ethical principles when developing and using AI technology."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
44·Changed·Item 1A › Risks Related to the Ownership of Our Common Stock › Our IPO occurred in March 2024. As such, there has only been a public market for our common stock for a relatively short period of time. The market price of our common stock may continue to be volatile, which could cause the value of your investment to decline, and we may not be able to meet investor or analyst expectations.
Summary · quote-checked
Added government shutdowns and international or armed conflicts to the listed events that may affect the company.
The added items identify new event categories associated with potential effects, changing the stated scope of the risk rather than merely rephrasing it.
Filing text · FY2024 10-K · filed Feb 14, 2025
• other events or factors, including those resulting from political conditions, election cycles, war or incidents of terrorism, increased tariffs, or responses to these events.
Filing text · FY2025 10-K · filed Feb 20, 2026
• other events or factors, including those resulting from political conditions, election cycles, [added] government shutdowns, international or armed conflicts, war or incidents of terrorism, increased tariffs, or responses to these events.
Cite this change
"• other events or factors, including those resulting from political conditions, election cycles, government shutdowns, international or armed conflicts, war or incidents of terrorism, increased tariffs, or responses to these events."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
45·Changed·Item 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.
Summary · quote-checked
Removed disclosure that the company is subject to privacy-policy terms and third-party obligations, while revising jurisdictional wording and adding artificial intelligence to the heading.
The removed sentence disclosed ongoing obligations to privacy policies and third parties, including customers, changing the stated dependency and compliance exposure. Other edits are wording changes.
Filing text · FY2024 10-K · filed Feb 14, 2025
There are numerous U.S. federal, state, local, and international laws and regulations regarding privacy, data protection, and cybersecurity that govern the collection, receipt, processing, and storage of personal information and other information. The scope of these laws and regulations is expanding and evolving, subject to differing interpretations, may be inconsistent [removed] among jurisdictions, or conflict with other rules.[removed] We are also subject to the terms of our privacy policies and obligations to third parties, including our customers, related to privacy, data protection, and cybersecurity.
Filing text · FY2025 10-K · filed Feb 20, 2026
There are numerous U.S. federal, state, local, and international laws and regulations regarding privacy, data protection, and cybersecurity that govern the collection, receipt, processing, and storage of personal information and other information. The scope of these laws and regulations is expanding and evolving, [added] and may be subject to differing interpretations, [added] which may be inconsistent [added] across jurisdictions, or conflict with other rules.
Cite this change
"There are numerous U.S. federal, state, local, and international laws and regulations regarding privacy, data protection, and cybersecurity that govern the collection, receipt, processing, and storage of personal information and other information."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
46·Changed·Item 1A › Risks Related to Our Business › We generally do not maintain long-term supply contracts with our third-party manufacturing partners, and any disruption in our supply of products could have a material adverse effect on our business, financial condition, and results of operations.
Summary · quote-checked
The supply-chain risk now specifies short-term demand impacts and adverse effects from insufficient materials, quality deterioration, and inability to pass higher costs to customers.
The added language introduces specific supply, quality, pricing, and cost-pass-through contingencies, substantively expanding the disclosed consequences of manufacturing-partner disruptions.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our third-party manufacturing partners may also extend lead times, limit supplies, place products on allocation, or increase prices that could lead to interruption of supply or increased demand in the industry. For example, the supply of these materials may be negatively impacted by increased trade tensions between the United States and its trading partners, particularly the People's Republic of China. Moreover, TSMC has increased and may increase in the future the wafer prices we pay. Our products are incorporated into complex devices and systems, which creates supply chain cross-dependencies. Due to these cross dependencies, any supply chain disruptions could impact the demand for our products in the short term. In the event that we cannot obtain sufficient quantities of materials in a timely manner or at reasonable prices from third-party manufacturing partners, the quality of the material deteriorates or we are not able to pass on higher manufacturing costs to our customers, our business, financial condition, and results of operations could be adversely impacted.
Filing text · FY2025 10-K · filed Feb 20, 2026
Our third-party manufacturing partners may also extend lead times, limit supplies, place products on allocation, or increase prices that could lead to interruption of supply or increased demand in the industry. For example, the supply of these materials may be negatively impacted by increased trade tensions between the United States and its trading partners, particularly the People's Republic of China. Moreover, TSMC has increased and may increase in the future the wafer prices we pay. Our products are incorporated into complex devices and systems, which creates supply chain cross-dependencies. Due to these cross dependencies, any supply chain disruptions could impact the demand for our products in[added] the short term. In the event that we cannot obtain sufficient quantities of materials in a timely manner or at reasonable prices from third-party manufacturing partners, the quality of the material deteriorates or we are not able to pass on higher manufacturing costs to our customers, our business, financial condition, and results of operations could be adversely impacted.
Cite this change
"the short term. In the event that we cannot obtain sufficient quantities of materials in a timely manner or at reasonable prices from third-party manufacturing partners, the quality of the material deteriorates or we are not able to pass on higher manufacturing costs to our customers, our business, financial condition, and results of operations could be adversely impacted."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
47·Changed·Item 1A › Risks Related to Our Business › We may pursue acquisitions, investments, joint ventures, and dispositions, which could adversely affect our results of operations, and any acquisitions we do make could disrupt our business and harm our financial condition.
Summary · quote-checked
The growth strategy now includes acquiring assets in addition to acquiring businesses, with the verb adjusted for grammatical agreement.
Adding assets expands the stated categories of acquisition targets, changing the substance of the disclosed growth strategy; the enables-to-enable edit is grammatical wording.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our growth strategy includes acquiring businesses that offer complementary products, services, and technologies, enhance our market coverage or technological capabilities or [removed] enables us to increase the number of engineering employees.
Filing text · FY2025 10-K · filed Feb 20, 2026
Our growth strategy includes acquiring businesses [added] and/or assets that offer complementary products, services, and technologies, enhance our market coverage or technological capabilities or [added] enable us to increase the number of engineering employees.
Cite this change
"Our growth strategy includes acquiring businesses and/or assets that offer complementary products, services, and technologies, enhance our market coverage or technological capabilities or enable us to increase the number of engineering employees."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
48·Changed·Item 1A › Risks Related to Our Business › We may pursue acquisitions, investments, joint ventures, and dispositions, which could adversely affect our results of operations, and any acquisitions we do make could disrupt our business and harm our financial condition.
Summary · quote-checked
The regulatory-approval risk was expanded to cover investments as well as acquisitions.
Adding investments introduces an additional transaction category subject to regulatory approval delays, conditions, or denial, broadening the stated risk exposure.
Filing text · FY2024 10-K · filed Feb 14, 2025
In addition, current and future changes to the U.S. and foreign regulatory approval process and requirements related to acquisitions may cause approvals to take longer than anticipated, not be forthcoming or contain burdensome conditions, which may prevent the transaction or jeopardize, delay or reduce the anticipated benefits of the transaction, and impede the execution of our business strategy.
Filing text · FY2025 10-K · filed Feb 20, 2026
In addition, current and future changes to the U.S. and foreign regulatory approval process and requirements related to [added] investments or acquisitions may cause approvals to take longer than anticipated, not be forthcoming or contain burdensome conditions, which may prevent the transaction or jeopardize, delay or reduce the anticipated benefits of the transaction, and impede the execution of our business strategy.
Cite this change
"requirements related to investments or acquisitions may cause approvals to take longer than anticipated"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
49·Changed·Item 1A › Risks Related to the Ownership of Our Common Stock › Sales of substantial amounts of our common stock in the public markets or the perception that sales might occur, could cause the trading price of our common stock to decline.
Summary · quote-checked
The disclosure no longer limits registration rights to common stock issuable upon conversion of specified shares.
Removing the conversion qualifier changes the stated scope of holders’ registration rights and the shares potentially subject to public resale.
Filing text · FY2024 10-K · filed Feb 14, 2025
Certain holders of our common stock have rights, subject to some conditions, to require us to file registration statements for the public resale of the common stock [removed] issuable upon conversion of such shares or to include such shares in registration statements that we may file for us or other stockholders. Any registration statement we file to register additional shares, whether as a result of registration rights or otherwise, could cause the trading price of our common stock to decline or be volatile.
Filing text · FY2025 10-K · filed Feb 20, 2026
Certain holders of our common stock have rights, subject to some conditions, to require us to file registration statements for the public resale of the common stock or to include such shares in registration statements that we may file for us or other stockholders. Any registration statement we file to register additional shares, whether as a result of registration rights or otherwise, could cause the trading price of our common stock to decline or be volatile.
Cite this change
"Certain holders of our common stock have rights, subject to some conditions, to require us to file registration statements for the public resale of the common stock or to include such shares in registration statements that we may file for us or other stockholders."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
50·Changed·Item 1A › Risks Related to Our Business › We may pursue acquisitions, investments, joint ventures, and dispositions, which could adversely affect our results of operations, and any acquisitions we do make could disrupt our business and harm our financial condition.
Summary · quote-checked
The paragraph expands potential divestitures and related sale risks to include assets, not only portions of the business.
Adding assets broadens the stated scope of contemplated dispositions and the associated ability-to-sell risk, changing the disclosed exposure beyond a stylistic revision.
Filing text · FY2024 10-K · filed Feb 14, 2025
From time to time, we may also seek to divest or wind down portions of our business, either acquired or otherwise, any of which could materially affect our cash flows and results of operations. Such dispositions involve risks and uncertainties, including our ability to sell such businesses on terms acceptable to us, or at all, disruption to other parts of our business, potential loss of employees or customers, or exposure to unanticipated liabilities or ongoing obligations to us following any such dispositions. In addition, dispositions may include the transfer of technology and/or the licensing of certain intellectual property rights to third parties, which could limit our ability to utilize such intellectual property rights or assert these rights against such third parties.
Filing text · FY2025 10-K · filed Feb 20, 2026
From time to time, we may also seek to divest or wind down [added] assets or portions of our business, either acquired or otherwise, any of which could materially affect our cash flows and results of operations. Such dispositions involve risks and uncertainties, including our ability to sell such [added] assets or businesses on terms acceptable to us, or at all, disruption to other parts of our business, potential loss of employees or customers, or exposure to unanticipated liabilities or ongoing obligations to us following any such dispositions. In addition, dispositions may include the transfer of technology and/or the licensing of certain intellectual property rights to third parties, which could limit our ability to utilize such intellectual property rights or assert these rights against such third parties.
Cite this change
"seek to divest or wind down assets or portions of our business, either acquired or otherwise"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
51·Changed·Item 1A › Risks Related to Our Business › The complexity of our products could result in unforeseen delays or expense or undetected defects, bugs, or security vulnerabilities, which could adversely affect the market acceptance of new products, damage our reputation with current or prospective customers, and materially and adversely affect our operating costs.
Summary · quote-checked
The disclosure changes the potentially expensed capitalized cost from production mask costs to production equipment costs.
The identified cost category changes, potentially altering the stated type and scope of costs that could affect results and financial condition.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our products may contain defects when they are first introduced or as new versions or enhancements are released, or their release may be delayed due to unforeseen difficulties during product development. If any of our products or third-party components used in our products, contain defects, bugs, vulnerabilities, or have reliability, quality, or compatibility problems, we may not be able to successfully design workarounds or resolve the issues in a timely manner. Furthermore, if any of these problems are not discovered until after we have commenced commercial production or deployment of a new product, we may be required to incur additional development costs, as well as costs to repair or replace our products, and expense previously capitalized production [removed] mask costs, all of which could materially adversely affect our reputation, business, results of operations, and/or financial condition.
Filing text · FY2025 10-K · filed Feb 20, 2026
Our products may contain defects when they are first introduced or as new versions or enhancements are released, or their release may be delayed due to unforeseen difficulties during product development. If any of our products or third-party components used in our products, contain defects, bugs, vulnerabilities, or have reliability, quality, or compatibility problems, we may not be able to successfully design workarounds or resolve the issues in a timely manner. Furthermore, if any of these problems are not discovered until after we have commenced commercial production or deployment of a new product, we may be required to incur additional development costs, as well as costs to repair or replace our products, and expense previously capitalized production [added] equipment costs, all of which could materially adversely affect our reputation, business, results of operations, and/or financial condition.
Cite this change
"Furthermore, if any of these problems are not discovered until after we have commenced commercial production or deployment of a new product, we may be required to incur additional development costs, as well as costs to repair or replace our products, and expense previously capitalized production equipment costs, all of which could materially adversely affect our reputation, business, results of operations, and/or financial condition."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
52·Changed·Item 1A › Risks Related to our Intellectual Property › Any potential dispute involving patents or other intellectual property could affect our customers, which could trigger our indemnification obligations to them and result in substantial expense to us.
Summary · quote-checked
The disclosure no longer states that some customer agreements lack maximum loss clauses or may create substantial liability.
Removing the maximum-loss-clause limitation changes the disclosed extent of potential indemnification liability and exposure under customer agreements.
Filing text · FY2024 10-K · filed Feb 14, 2025
In any potential dispute involving patents or other intellectual property, our customers could also become the target of litigation. Our agreements with customers generally include indemnification or other provisions under which we agree to indemnify or otherwise be liable to them for losses suffered or incurred as a result of third-party claims of intellectual property infringement. Large indemnity payments could harm our business, financial condition, and results of operations. From time to time, customers require us to indemnify or otherwise be liable to them for breach of confidentiality or failure to implement adequate security measures with respect to their intellectual property and trade secrets. Although we normally contractually limit our liability with respect to such obligations, certain of our customer agreements may not include[removed] maximum loss clauses, which may result in substantial liability. Any litigation against our customers could trigger indemnification obligations under some of our agreements, which could result in substantial expense to us, and which could materially and adversely affect our financial results.
Filing text · FY2025 10-K · filed Feb 20, 2026
In any potential dispute involving patents or other intellectual property, our customers could also become the target of litigation. Our agreements with customers generally include indemnification or other provisions under which we agree to indemnify or otherwise be liable to them for losses suffered or incurred as a result of third-party claims of intellectual property infringement. Large indemnity payments could harm our business, financial condition, and results of operations. From time to time, customers require us to indemnify or otherwise be liable to them for breach of confidentiality or failure to implement adequate security measures with respect to their intellectual property and trade secrets. Although we normally contractually limit our liability with respect to such obligations, certain of our customer agreements may not include maximum loss clauses, which may result in substantial liability. Any litigation against our customers could trigger indemnification obligations under some of our agreements, which could result in substantial expense to us, and which could materially and adversely affect our financial results.
Cite this change
"Although we normally contractually limit our liability with respect to such obligations, certain of our customer agreements may not include"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
53·Changed·Item 1A › Risks Related to the Ownership of Our Common Stock › Our issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans, or otherwise will dilute all other stockholders and could negatively affect our results of operations.
Summary · quote-checked
The disclosure specifies that acquisitions or investments in complementary businesses, products, or technologies may be funded by issuing equity securities.
The added language identifies specific acquisition targets and introduces equity securities as consideration, expanding the stated dilution risk beyond a general possibility of acquisitions or investments.
Filing text · FY2024 10-K · filed Feb 14, 2025
We expect to issue additional capital stock in the future that will result in dilution to all other stockholders. We expect to grant equity awards to employees, directors, consultants, and advisors under our stock incentive plans. We may also raise capital through equity financings in the future. As part of our business strategy, we may acquire or make investments in complementary companies, products, or technologies and issue equity securities to pay for any such acquisition or investment. Any such issuances of additional capital stock may cause stockholders to experience significant dilution of their ownership interests and the per share value of our common stock to decline.
Filing text · FY2025 10-K · filed Feb 20, 2026
We expect to issue additional capital stock in the future that will result in dilution to all other stockholders. We expect to grant equity awards to employees, directors, consultants, and advisors under our stock incentive plans. We may also raise capital through equity financings in the future. As part of our business strategy, we may acquire or make investments[added] in complementary companies, products, or technologies and issue equity securities to pay for any such acquisition or investment. Any such issuances of additional capital stock may cause stockholders to experience significant dilution of their ownership interests and the per share value of our common stock to decline.
Cite this change
"As part of our business strategy, we may acquire or make investments in complementary companies, products, or technologies and issue equity securities to pay for any such acquisition or"
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
54·Changed·Item 1A › Risks Related to our Intellectual Property › Our failure to protect our intellectual property rights adequately could impair our ability to compete effectively or to defend ourselves from litigation, which could harm our business, financial condition, and results of operations.
Summary · quote-checked
The paragraph updates patent counts and adds one issued foreign patent, changing the disclosed scope of the company’s intellectual property portfolio.
The changes are not merely annual roll-forwards: they add an issued foreign patent and alter issued and pending patent counts, changing the disclosed intellectual property rights and protection capacity.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our success depends in part upon protecting our intellectual property. We rely primarily on patent, copyright, trademark, and trade secret laws, as well as intellectual property assignment and confidentiality and non-disclosure agreements and other methods, to protect and establish our rights in our proprietary technologies and know-how. As of December 31, [removed] 2024 we have been issued [removed] 18 patents in the United States and [removed] have an additional 28 patent applications pending in the United States, and [removed] four patent applications pending in foreign jurisdictions. We cannot guarantee that any pending or future patent applications will be issued to have the coverage originally sought, and even if the pending patent applications are granted, the rights granted to us may not be meaningful or provide us with any commercial advantage. Additionally, our patents could be opposed, contested, narrowed, circumvented, challenged, abandoned, or designed around by our competitors or be declared invalid or unenforceable in judicial or administrative proceedings. The patent prosecution process is expensive, time-consuming, and complex, and we may not be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output in time to obtain patent protection. Failure to timely seek patent protection on products or technologies generally precludes us from seeking future patent protection on these products or technologies. Even if we do timely seek patent protection, the coverage claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted after issuance, and as a result we can give no assurance that any patents that have issued to may issue in the future will protect our current and future products, will provide us with any competitive advantage, or will not be challenged, invalidated or circumvented in the future.
Filing text · FY2025 10-K · filed Feb 20, 2026
Our success depends in part upon protecting our intellectual property. We rely primarily on patent, copyright, trademark, and trade secret laws, as well as intellectual property assignment and confidentiality and non-disclosure agreements and other methods, to protect and establish our rights in our proprietary technologies and know-how. As of December 31, [added] 2025, we have been issued [added] 26 patents in the United States and [added] one patent in foreign jurisdictions. In addition, we have 35 patent applications pending in the United States, and [added] five patent applications pending in foreign jurisdictions. We cannot guarantee that any pending or future patent applications will be issued to have the coverage originally sought, and even if the pending patent applications are granted, the rights granted to us may not be meaningful or provide us with any commercial advantage. Additionally, our patents could be opposed, contested, narrowed, circumvented, challenged, abandoned, or designed around by our competitors or be declared invalid or unenforceable in judicial or administrative proceedings. The patent prosecution process is expensive, time-consuming, and complex, and we may not be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output in time to obtain patent protection. Failure to timely seek patent protection on products or technologies generally precludes us from seeking future patent protection on these products or technologies. Even if we do timely seek patent protection, the coverage claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted after issuance, and as a result we can give no assurance that any patents that have issued to may issue in the future will protect our current and future products, will provide us with any competitive advantage, or will not be challenged, invalidated or circumvented in the future.
Cite this change
"As of December 31, 2025, we have been issued 26 patents in the United States and one patent in foreign jurisdictions. In addition, we have 35 patent applications pending in the United States, and five patent applications pending in foreign jurisdictions."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
55·Changed·Item 1A › Risks Related to Our Business › Our business, financial condition, and results of operations could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which we conduct business.
Summary · quote-checked
The disclosure changes the period over which inflation-related increases in labor, supply, and operating costs were observed from the last year to recent years.
This broadens the stated duration of inflation-related cost increases, changing the described persistence of the operating expense exposure rather than merely rolling forward a reporting date.
Filing text · FY2024 10-K · filed Feb 14, 2025
Furthermore, weak economic conditions have in the past and may in the future make it more difficult to collect on outstanding accounts receivable and increase our expenses. Specifically, our distributors or customers may fail to make payments when due, default under their agreements with us, or become insolvent or declare bankruptcy, or a supplier may determine that it will no longer do business with us as a customer. Additionally, a distributor, customer or supplier could be adversely affected by any of the liquidity or other risks that are described above as factors that could result in material adverse impacts on us, including but not limited to delayed access or loss of access to uninsured deposits or loss of the ability to draw on existing credit facilities involving a troubled or failed financial institution. Further, in [removed] the last year as a result of inflation, we have seen labor costs, product supply costs, and other operating expenses rise due to high rates of inflation, but have not been able to offset these costs with higher prices of our products. If customers or prospective customers elect not to purchase our products, as a result of a weak economy or rising inflation and increased costs or otherwise, or our distributors are unable to continue to distribute our products, our business, results of operations, and financial condition could be adversely affected.
Filing text · FY2025 10-K · filed Feb 20, 2026
Furthermore, weak economic conditions have in the past and may in the future make it more difficult to collect on outstanding accounts receivable and increase our expenses. Specifically, our distributors or customers may fail to make payments when due, default under their agreements with us, or become insolvent or declare bankruptcy, or a supplier may determine that it will no longer do business with us as a customer. Additionally, a distributor, customer or supplier could be adversely affected by any of the liquidity or other risks that are described above as factors that could result in material adverse impacts on us, including but not limited to delayed access or loss of access to uninsured deposits or loss of the ability to draw on existing credit facilities involving a troubled or failed financial institution. Further, in [added] recent years, we have seen labor costs, product supply costs, and other operating expenses rise due to high rates of inflation, but have not been able to offset these costs with higher prices of our products. If customers or prospective customers elect not to purchase our products, as a result of a weak economy or rising inflation and increased costs or otherwise, or our distributors are unable to continue to distribute our products, our business, results of operations, and financial condition could be adversely affected.
Cite this change
"Further, in recent years, we have seen labor costs, product supply costs, and other operating expenses rise due to high rates of inflation, but have not been able to offset these costs with higher prices of our products."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
56·Changed·Item 1A › Risks Related to Our Business › We make substantial investments in research and development, and unsuccessful investments could materially adversely affect our business, financial condition, and results of operations.
Summary · quote-checked
The disclosure adds that research and development investments are often made well ahead of anticipated product revenue, alongside rolled-forward spending figures.
The added timing statement changes the described investment exposure; the fiscal periods and amounts otherwise roll forward and do not independently change the risk.
Filing text · FY2024 10-K · filed Feb 14, 2025
The industry in which we compete is characterized by rapid technological change, changes in customer requirements, frequent new product introductions and enhancements, short product cycles and evolving industry standards, and new delivery methods. In addition, the fabrication of semiconductor products has transitioned over time to increasingly smaller line width geometries, and failure to successfully transition to product designs utilizing smaller geometry process nodes could impair our competitive position. In order to remain competitive, we have made, and expect to continue to make, significant investments in research and [removed] development. For the years ended December 31, [removed] 2024 and 2023, research and developments expenses were [removed] $200.8 million and [removed] $73.4 million, respectively. If we fail to develop new and enhanced products and technologies, if we focus on technologies that do not become widely adopted, or if new competitive technologies or industry standards that we do not support become widely accepted, demand for our products may be reduced. Increased investments in research and development or unsuccessful research and development efforts could cause our cost structure to fall out of alignment with demand for our products, which would have a negative impact on our financial results.
Filing text · FY2025 10-K · filed Feb 20, 2026
The industry in which we compete is characterized by rapid technological change, changes in customer requirements, frequent new product introductions and enhancements, short product cycles and evolving industry standards, and new delivery methods. In addition, the fabrication of semiconductor products has transitioned over time to increasingly smaller line width geometries, and failure to successfully transition to product designs utilizing smaller geometry process nodes could impair our competitive position. In order to remain competitive, we have made, and expect to continue to make, significant investments in research and [added] development and often well ahead of the anticipated product revenue. For the years ended December 31, [added] 2025 and 2024, research and developments expenses were [added] $304.0 million and [added] $200.8 million, respectively. If we fail to develop new and enhanced products and technologies, if we focus on technologies that do not become widely adopted, or if new competitive technologies or industry standards that we do not support become widely accepted, demand for our products may be reduced. Increased investments in research and development or unsuccessful research and development efforts could cause our cost structure to fall out of alignment with demand for our products, which would have a negative impact on our financial results.
Cite this change
"In order to remain competitive, we have made, and expect to continue to make, significant investments in research and development and often well ahead of the anticipated product revenue."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
57·Changed·Item 1A › Risks Related to Our Business › Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.
Summary · quote-checked
The disclosure changes future resource spending from likely required to definitively required.
The wording changes the certainty of a future cybersecurity-related expenditure obligation, making the stated commitment more definite.
Filing text · FY2024 10-K · filed Feb 14, 2025
Further, we continue to devote resources to protect our systems and data from unauthorized access or misuse, and we will [removed] likely be required to expend greater resources in the future. However, we cannot guarantee that our risk management processes will be effective at mitigating the risk to our information technology systems.
Filing text · FY2025 10-K · filed Feb 20, 2026
Further, we continue to devote resources to protect our systems and data from unauthorized access or misuse, and we will be required to expend greater resources in the future. However, we cannot guarantee that our risk management processes will be effective at mitigating the risk to our information technology systems.
Cite this change
"Further, we continue to devote resources to protect our systems and data from unauthorized access or misuse, and we will be required to expend greater resources in the future."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
58·Changed·Item 1A › Risks Related to Our Business › If we are unable to accurately predict end customer demand, or if our distributors or end customers' manufacturing partners cancel or change their orders, we may hold excess or obsolete inventory, which would reduce our gross margins and may damage our relationships with our customers.
Summary · quote-checked
The risk disclosure adds that significant excess inventory could consequently result in an inventory write-off.
The revised sentence explicitly identifies inventory write-offs as a consequence of excess inventory, adding a specific financial risk beyond the prior general inventory statement.
Filing text · FY2024 10-K · filed Feb 14, 2025
Our revenue and operating results could fluctuate materially and could be materially and disproportionately impacted by the purchasing decisions of our end customers. Due to the inability to predict demand or other reasons, some of our distributors and end customers' manufacturing partners may accumulate excess inventories and, as a consequence, defer purchases of our products. For example, in the first quarter of 2023 we had a $9.7 million charge to write down inventory in excess of our sales forecast for a legacy customer system. Anticipating demand is difficult because our end customers face unpredictable demand for their own products and/or deployment of their own systems. If we overestimate end customer demand, or end customer demand is otherwise impacted by other factors impacting our assumptions, we might produce significant excess [removed] inventory, which would reduce our gross margin and adversely affect our financial results. Conversely, if we underestimate customer demand or if insufficient manufacturing capacity is available, we may miss revenue opportunities, potentially lose market share and damage our customer relationships. In addition, as an increasing number of our products are being incorporated into end customer systems, we anticipate greater fluctuations in demand for our products, which makes it more difficult to forecast end customer demand.
Filing text · FY2025 10-K · filed Feb 20, 2026
Our revenue and operating results could fluctuate materially and could be materially and disproportionately impacted by the purchasing decisions of our end customers. Due to the inability to predict demand or other reasons, some of our distributors and end customers' manufacturing partners may accumulate excess inventories and, as a consequence, defer purchases of our products. For example, in the first quarter of 2023 we had a $9.7 million charge to write down inventory in excess of our sales forecast for a legacy customer system. Anticipating demand is difficult because our end customers face unpredictable demand for their own products and/or deployment of their own systems. If we overestimate end customer demand, or end customer demand is otherwise impacted by other factors impacting our assumptions, we might produce significant excess [added] inventory and consequently inventory write-off, which would reduce our gross margin and adversely affect our financial results. Conversely, if we underestimate customer demand or if insufficient manufacturing capacity is available, we may miss revenue opportunities, potentially lose market share and damage our customer relationships. In addition, as an increasing number of our products are being incorporated into end customer systems, we anticipate greater fluctuations in demand for our products, which makes it more difficult to forecast end customer demand.
Cite this change
"If we overestimate end customer demand, or end customer demand is otherwise impacted by other factors impacting our assumptions, we might produce significant excess inventory and consequently inventory write-off, which would reduce our gross margin and adversely affect our financial results."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
59·Figures updated·Item 1A › Risks Related to the Ownership of Our Common Stock › Sales of substantial amounts of our common stock in the public markets or the perception that sales might occur, could cause the trading price of our common stock to decline.
Summary · quote-checked
Outstanding options and RSU/PSU awards decreased, while warrants remained unchanged, altering the disclosed potential future issuance of common shares.
The updated figures change the disclosed equity overhang and potential share issuance exposure, so a reader could draw a different conclusion about dilution and market supply.
Filing text · FY2024 10-K · filed Feb 14, 2025
In addition, as of December 31, [removed] 2024, we had (i) [removed] 5,285,404 options outstanding that, if fully exercised, would result in the issuance of [removed] 5,285,404 shares of common stock, (ii) [removed] 13,775,704 RSU and PSU awards outstanding that would result in the issuance of [removed] 13,775,704 shares of common stock upon settlement, and (iii) 2,442,360 warrants outstanding that, if fully exercised, would result in the issuance of 2,442,360 shares of common stock. All of the shares of common stock issuable upon the exercise of stock options, subject to RSU awards and the shares reserved for future issuance under our equity incentive plans have been registered on a registration statement on Form S-8 under the Securities Act. Accordingly, these shares can be freely sold in the public market upon issuance, subject to volume limitations under Rule 144 for our executive officers and directors and applicable vesting requirements.
Filing text · FY2025 10-K · filed Feb 20, 2026
In addition, as of December 31, [added] 2025, we had (i) [added] 2,721,076 options outstanding that, if fully exercised, would result in the issuance of [added] 2,721,076 shares of common stock, (ii) [added] 9,531,296 RSU and PSU awards outstanding that would result in the issuance of [added] 9,531,296 shares of common stock upon settlement, and (iii) 2,442,360 warrants outstanding that, if fully exercised, would result in the issuance of 2,442,360 shares of common stock. All of the shares of common stock issuable upon the exercise of stock options, subject to RSU awards and the shares reserved for future issuance under our equity incentive plans have been registered on a registration statement on Form S-8 under the Securities Act. Accordingly, these shares can be freely sold in the public market upon issuance, subject to volume limitations under Rule 144 for our executive officers and directors and applicable vesting requirements.
Cite this change
"In addition, as of December 31, 2025, we had (i) 2,721,076 options outstanding that, if fully exercised, would result in the issuance of 2,721,076 shares of common stock, (ii) 9,531,296 RSU and PSU awards outstanding that would result in the issuance of 9,531,296 shares of common stock upon settlement, and (iii) 2,442,360 warrants outstanding that, if fully exercised, would result in the issuance of 2,442,360 shares of common stock."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
60·Figures updated·Item 1A › Risks Related to the Ownership of Our Common Stock › Our executive officers, directors, and stockholders, if they choose to act together, have the ability to control or significantly influence all matters submitted to shareholders for approval.
Summary · quote-checked
The reported aggregate ownership concentration decreased from approximately 55.8% as of December 31, 2024 to 37.9% as of December 31, 2025.
Although the date rolls forward, the ownership percentage materially changes the stated degree of shareholder control and potential influence over corporate matters.
Filing text · FY2024 10-K · filed Feb 14, 2025
As of December 31, [removed] 2024, our executive officers, directors, and greater than 5% stockholders, in the aggregate, beneficially owned approximately [removed] 55.8% of our outstanding common stock (assuming no exercise of outstanding options warrants or settlement of RSUs in shares upon vesting). As a result, such persons, acting together, have the ability to control or significantly influence all matters submitted to our board of directors or shareholders for approval, including the appointment of our management, the election and removal of directors and approval of any significant transaction, as well as our management and business affairs. In addition, this concentration of ownership may have the effect of delaying, deferring, or preventing a change in control, impeding a merger, consolidation, takeover or other business combination involving us, or discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of our business, even if such a transaction would benefit other shareholders.
Filing text · FY2025 10-K · filed Feb 20, 2026
As of December 31, [added] 2025, our executive officers, directors, and greater than 5% stockholders, in the aggregate, beneficially owned approximately [added] 37.9% of our outstanding common stock (assuming no exercise of outstanding options warrants or settlement of RSUs in shares upon vesting). As a result, such persons, acting together, have the ability to control or significantly influence all matters submitted to our board of directors or shareholders for approval, including the appointment of our management, the election and removal of directors and approval of any significant transaction, as well as our management and business affairs. In addition, this concentration of ownership may have the effect of delaying, deferring, or preventing a change in control, impeding a merger, consolidation, takeover or other business combination involving us, or discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of our business, even if such a transaction would benefit other shareholders.
Cite this change
"As of December 31, 2025, our executive officers, directors, and greater than 5% stockholders, in the aggregate, beneficially owned approximately 37.9% of our outstanding common stock (assuming no exercise of outstanding options warrants or settlement of RSUs in shares upon vesting)."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
61·Merged·Item 1A › Risks Related to Our Business › We may be unsuccessful in anticipating and responding to new market trends and evolving industry standards, developing and selling new products, or penetrating new markets.
Summary · quote-checked
Adds UALinkTM as another connectivity standard described as being in the early stages of market adoption.
The newly named standard is tied to the disclosure’s risk concerning evolving industry standards and market adoption, adding substantive exposure rather than merely rephrasing existing text.
Filing text · FY2024 10-K · filed Feb 14, 2025
Products for our target markets are based on industry standards that are continually evolving, and industry standards are often developed and promoted by larger companies who are industry leaders and provide other components of the systems into which our products are incorporated. In choosing products to develop, we also make certain assumptions[removed] about which industry standards we believe will be adopted by industry leaders. For example, CXL connectivity solutions are in the early stages of market adoption. If our assumptions are incorrect, and larger companies do not support the same industry standards that we do, or if competing standards emerge, it could be difficult for our products to meet the requirements of certain customers. As a result, if we fail to introduce new products or new generations of our existing products that meet prevailing industry standards and the needs of our customers, or penetrate new markets in a timely fashion, and our designs do not gain acceptance, we will likely lose market share and our competitive position, potentially on an extended basis, and our operating results will be adversely affected.
Filing text · FY2025 10-K · filed Feb 20, 2026
Products for our target markets are based on industry standards that are continually evolving, and industry standards are often developed and promoted by larger companies who are industry leaders and provide other components of the systems into which our products are incorporated. In choosing products to develop, we also make certain assumptions[added] about which industry standards we believe will be adopted by industry leaders. For example, CXL connectivity solutions [added] and UALinkTM are in the early stages of market adoption. If our assumptions are incorrect, and larger companies do not support the same industry standards that we do, or if competing standards emerge, it could be difficult for our products to meet the requirements of certain customers. As a result, if we fail to introduce new products or new generations of our existing products that meet prevailing industry standards and the needs of our customers, or penetrate new markets in a timely fashion, and our designs do not gain acceptance, we will likely lose market share and our competitive position, potentially on an extended basis, and our operating results will be adversely affected.
Cite this change
"For example, CXL connectivity solutions and UALinkTM are in the early stages of market adoption."
Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.
2 of 38 shown · Ordered by the model, quote-checked
01·Changed·Item 7 › Summary of Financial Highlights
Summary · quote-checked
The disclosure changed from explaining cash used in operating activities to reporting net income and its year-over-year increase.
The MD&A metric, direction, and drivers changed substantively: a cash-flow use with operating explanations was replaced by positive net income and its increase.
Why the model ranked it here
The company reports positive net income after previously reporting a loss, materially changing the earnings picture.
Filing text · FY2024 10-K · filed Feb 14, 2025
Net [removed] cash used in operating activities for the year ended December 31, [removed] 2023 of $12.7 million resulted primarily from a net loss of [removed] $26.3 million and cash used in operating assets and liabilities of $9.7 million offset by non-cash charges of $23.2 million primarily consisting of stock-based compensation of $10.7 million, an inventory write down of $10.3 million and depreciation of $1.8 million. Cash used in operating assets and liabilities during the period was primarily from a $5.6 million increase in inventory primarily due to build up for anticipated demand, a $4.3 million decrease in accounts payable primarily due to timing of payments, and a $1.3 million decrease in operating lease liability due to the maturing of the lease, and $0.7 million decrease in prepaid expenses and other assets due to timing. These cash flow uses were partially offset by a $2.4 million decrease in accounts receivable due to timing of customer payments.
Filing text · FY2025 10-K · filed Feb 20, 2026
Net [added] income was $219.1 million for the year ended December 31, [added] 2025 compared to a net loss of [added] $83.4 million for the year ended December 31, 2024, representing a $302.6 million year-over-year increase.
Cite this change
"Net income was $219.1 million for the year ended December 31, 2025 compared to a net loss of $83.4 million for the year ended December 31, 2024, representing a $302.6 million year-over-year increase."
Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.
Summaries are written by a model and checked against the quoted text. The quotes are the record.
02·Changed·Item 7 › Change in Cash Flows from Operating Activities
Summary · quote-checked
Operating cash flow discussion changed from 2024 results and drivers to 2025 results, including a substantial increase and different underlying drivers.
The reported cash-flow direction, amounts, and explanations changed. The current paragraph identifies increased net income and unfavorable working-capital changes, replacing the prior period’s loss and specific operating-asset movements.
Why the model ranked it here
Operating cash generation increased substantially, with the drivers shifting from IPO-related non-cash items and losses to net income and working-capital changes.
Filing text · FY2024 10-K · filed Feb 14, 2025
Net cash provided by operating activities for the year ended December 31, [removed] 2024 of $136.7 million resulted primarily from non-cash charges of $233.4 million primarily related to $234.6 million in stock-based compensation expense partially offset by a net loss of $83.4 million and cash used by operating assets and liabilities of $13.3 million. Cash used in operating assets and [removed] liabilities during the period was primarily [removed] from an increase of $30.5 million in accounts receivable due to higher product sales and timing of customer payments, $19.3 million increase in inventory for anticipated future demand, a $13.0 million increase in prepaid expenses and other assets primarily related to accrued interest receivable on our short-term investments, and $2.4 million decrease in operating lease liability. The net cash flow used in operating assets and liabilities were partially offset by $31.0 million increase in [removed] accrued expenses and other [removed] liabilities primarily due to [removed] accrued customer deposits and timing of payments, a $20.9 million increase in accounts [removed] payable primarily due to timing of [removed] payments, as well as increase in purchases.
Filing text · FY2025 10-K · filed Feb 20, 2026
Net cash provided by operating activities for the year ended December 31, [added] 2025 was $319.3 million, compared to $136.7 million for the comparable period in 2024. The $182.6 million increase in net cash provided by operating activities was a result of a $302.6 million increase in net income, partially offset by both lower non-cash charges of $67.3 million and an unfavorable change of $52.7 million from changes in operating assets and [added] liabilities. The lower non-cash charges of $67.3 million was primarily [added] due to a $74.6 million decrease in non-cash stock-based compensation expense, partially offset by increased warrants contra revenue of $4.1 million and increased depreciation and amortization expense of $3.7 million. The unfavorable change of $52.7 million from changes in operating assets and liabilities was primarily attributable to (i) a $21.9 million unfavorable change in accounts payables and accrued other liabilities primarily due to the timing of payments, (ii) a $20.7 million increase in [added] the changes of the prepaid expenses and other [added] assets primarily due to [added] prepayment for a research and development vendor and a higher income tax receivable from excess tax benefits related to equity compensation, and (iii) a $13.9 million unfavorable change in accounts [added] receivable due to [added] higher product sales and the timing of [added] customer payments. These unfavorable changes were partially offset by a reduced inventory balance of $6.3 million.
Cite this change
"Net cash provided by operating activities for the year ended December 31, 2025 was $319.3 million, compared to $136.7 million for the comparable period in 2024. The $182.6 million increase in net cash provided by operating activities was a result of a $302.6 million increase in net income, partially offset by both lower non-cash charges of $67.3 million and an unfavorable change of $52.7 million from changes in operating assets and liabilities."
Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.
At most one email a day, and only when a company we cover files. Over the last twelve months that averaged about 5 days a month, unevenly: 12 in the busiest month and 1 in the quietest. You confirm by email first; nothing is sent until you do.